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ABSTRACT 
THE ROLE OF AMP-ACTIVATED PROTEIN KINASE IN MOUSE 
OOCYTE MATURATION AND SUBSEQUENT EGG ACTIVATION 
 
Ru Ya, B.S 
Marquette University, 2013 
Mammalian oogenesis begins during fetal development. Oocytes enter meiosis 
and arrest at prophase I before birth. Meiosis resumes after proper hormonal signaling, 
the oocyte completes meiosis I, and then ovulates in metaphase II, at which stage it 
arrests until fertilization occurs. Egg activation occurs upon sperm fertilization, which 
includes various physiological processes including calcium influx, release of cortical 
granules, and completion of meiosis II. However, egg activation can also occur without 
fertilization, which compromises the later embryonic development. The developmental 
period from prophase I to metaphase II is referred as oocyte maturation, and involves 
crucial dynamic change of the cytoskeleton network. The underlying mechanisms that 
control meiotic regulation still remain elusive. It is well established that a high cAMP 
level is required to maintain prophase I arrest, whereas mitogen activated protein kinase 
(MAPK) activity is needed for later metaphase II arrest of the oocyte.  cAMP declines 
during meiotic resumption by the activation of phosphodiesterase (PDE), which converts 
cAMP into AMP. Elevated AMP activates AMP-activated protein kinase (AMPK). It was 
suggested that activation of AMPK provides an additional stimulus for meiotic 
resumption, and consistent with this idea, activation of AMPK mediates meiotic 
resumption both in vivo and in vitro. However, the role of AMPK in later process 
remained to be determined. 
My research is focused on the role of AMPK after meiotic resumption. It is 
composed of three parts: (1) the effect of AMPK activation on completion of oocyte 
maturation; (2) the regulation of AMPK activity by spindle microtubules; and (3) AMPK 
regulation of egg activation. Results indicate that AMPK promotes anaphase onset and 
formation of the first polar body (PB). Meanwhile, the activity and localization of AMPK 
is dependent on spindle microtubule integrity. In addition, AMPK suppresses premature 
activation of oocytes by maintaining MAPK activity.  
 
 
	   i	  
ACKNOWLEGEMENT 
Ru Ya, B.S 
My deepest gratitude goes to my advisor Dr. Stephen Downs, for all of his 
support, patience and encouragement. It is very fortunate for me to have him as my 
mentor. He opened the whole new scientific world to me and brought me the excitement 
of the research. His enthusiasm and positive attitude helped me overcome the obstacles in 
my research work. Without his guidance and patience, this dissertation would not have 
been possible.  
I am extremely grateful to my committee members, Dr. Gail Waring, Dr. Pinfen 
Yang, Dr. Edward Blumenthal and Dr. Allison Abbott. They provided me with a lot of 
valuable suggestions regarding my research and shared their career development 
experiences with me, which were extremely helpful. 
I am thankful to my lab member, Deepa Valsangkar, for her help on my research 
and the joy she brings to the lab. In addition, I would also like to thank everyone that I 
have met and worked with in this department.  
Last but not least, my family and friends, I could not have made it this far without 
their unconditional love and support. Thanks for their encouragement and the tremendous 
help. Their support gave me strength, and helped me stay focused.  
	   ii	  
TABLE OF CONTENTS 
ACKNOWLEDGEMENT………………………………………………………………...i 
LIST OF FIGURES ............................................................................................................ iv	  
ABBREVIATIONS ............................................................................................................ vi	  
BACKGROUND ................................................................................................................. 1	  
CHAPTER I: A ROLE OF AMPK THOUGHOUT MEIOTIC MATURATION IN THE 
MOUSE OOCYTE: EVIDENCE FOR PROMOTION OF POLAR BODY 
FORMATION AND SUPPRESSION OF PREMATURE ACTIVATION ..................... 17	  
Summary ................................................................................................................ 17	  
Introduction ........................................................................................................... 18	  
Materials and Methods .......................................................................................... 20	  
Results ................................................................................................................... 23	  
Discussion .............................................................................................................. 38	  
Chapter II: PERTURBING MICROTUBLE INTEGRITY BLOCKS AMP-ACTIVATED 
PROTEIN KINASE-INDUCED MEIOTIC RESUMPTION IN CULTURED MOUSE 
OOCYTES ......................................................................................................................... 44	  
Summary ................................................................................................................ 44	  
Introduction ........................................................................................................... 46	  
Materials and Methods .......................................................................................... 48	  
Results ................................................................................................................... 51	  
Discussion .............................................................................................................. 63	  
CHAPTER III: SUPPRESSION OF CHEMICALLY INDUCED AND SPONTANEOUS 
MOUSE OOCYTE ACTIVATION BY AMP-ACTIVATED PROTEIN KINASE ........ 70	  
Summary ................................................................................................................ 70	  
Introduction ........................................................................................................... 71	  
	   iii	  
Materials and Methods .......................................................................................... 74	  
Results ................................................................................................................... 79	  
Discussion .............................................................................................................. 95	  
SUMMARY AND CONCLUSION ................................................................................ 103	  
BIBLIOGRAPHY ........................................................................................................... 111	  
  
	   iv	  
LIST OF FIGURES 
Figure 1 Folliculogenesis .................................................................................................... 3 
Figure 2 Overview of Oocyte Maturation ........................................................................... 5 
Figure 3 Regulation of Oocyte Meiotic Arrest .................................................................... 7 
Figure 4 Signals for Meiotic Resumption ........................................................................... 9 
Figure 5 The general role of AMPK in the somatic cells .................................................. 12 
Figure 6 The proposed model of AMPK involvement in meiotic induction (adapted from 
Downs et al., 2002) .................................................................................................... 13 
Figure 7 In vitro culture system for studying oocyte maturation (adapted from (Downs, 
2010) .......................................................................................................................... 16 
Figure 1. 1 Effect of AMPK on PB rate and kinetics ........................................................ 26 
Figure 1. 2 Effect of AMPK inhibitors on PB formation .................................................. 28 
Figure 1. 3 Effect of delaying AICAR or Compound C exposure on PB and activation .. 29 
Figure 1. 4 Effect of priming on PB formation and oocyte activation .............................. 32 
Figure 1. 5 Immunolocalization of active AMPK throughout oocyte maturation ............ 34 
Figure 1. 6 Localization of active AMPK in maturing oocytes in vivo ............................. 35 
Figure 1. 7 Immunolocalization of the alpha 1 catalytic subunit of AMPK ..................... 37 
Figure 2. 1 Effects of nocodazole treatment on meiotic resumption and AMPK 
activation…………………………………………………………………………………53 
Figure 2. 2 Effect of additional microtubule-targeted agents on FSH- and AICAR-
induced maturation in vitro ........................................................................................ 56 
Figure 2. 3 Immunofluorescent staining of active AMPK and tubulin ............................. 59 
Figure 2. 4 Effect of AMPK modulators on spontaneous maturation, early spindle 
formation and spinlde periphery movement .............................................................. 62 
Figure 3. 1 Schematic diagram of activation protocols……………………………….....80 
Figure 3. 2 Effect of AMPK stimulation and hormones on strontium-induced activation 83 
	   v	  
Figure 3. 3 Maintenance of MAPK1/3 activity in oocyte treated with AICAR( AIC) or 
AMP during maturation ............................................................................................. 85 
Figure 3. 4 Treatment with AICAR on A23187/puromycin- and ethanol-induced 
activation ................................................................................................................... 87 
Figure 3. 5 Effect of AMPK on activation of in vivo matured oocytes ............................. 89 
Figure 3. 6 Effects of AMPK stimulation on LT/SvEiJ oocytes ....................................... 92 
Figure 3. 7 Immunofluoresecent staining in LT oocytes ................................................... 94 
Figure 4. 1 The Role of AMPK in Mouse Oocyte Maturation……………………........104 
 
  
	   vi	  
ABBREVIATIONS 
Ana: anaphase  
CEO: cumulus cell-enclosed oocytes 
DO: denuded oocyte 
GV: germinal vesicle 
GVB: germinal vesicle breakdown 
MI: metaphase I 
MII: metaphase II 
PB: polar body 
Enzymes and Proteins 
ACC: acetyl-CoA carboxylase 
AMPK: AMP-activated protein kinase  
APC: anaphase promoting complex 
CDK1: cyclin dependent kinase 1 
CSF: cytostatic factor 
PDE: phosphodiesterase 
Emi2: early mitotic inhibitor 2 
MAPK1/3: mitogen activated protein kinase1/3 (same as ERK1/2) 
MPF: maturation promoting factor 
MRLC: myosin regulatory light chain 
	   vii	  
NPPC: natriuretic peptide type C 
Npr2: natriuretic peptide receptor 2  
PKA: cAMP-dependent protein kinase 
Hormones 
FSH: follicle-stimulating hormone 
hCG: human chorionic gonadotropin 
LH: luteinizing hormone 
PMSG: pregnant mare’s serum gonadotropin  
Others 
AR: amphiregulin 
B6SJL mice: C57BL/6J×SJL mice 
Con: control 
EGF: epidermal growth factor  
LT oocyte: LT/SvEiJ mouse oocyte 
MEM: minimum essential medium 
MT: microtubule 
MTOC: microtubule organizing center 
ODPF: oocyte–derived paracrine factors  
PGC: primordial germ cells  
PT172 antibody: anti-phospho AMPK antibody 
SAC: spindle assembly checkpoint  
	   viii	  
Chemicals 
2-D-glucose: 2-deoxy-D-glucose 
8-Br-Ado: 8-bromo-adenosine 
AICAR (AIC): 5-aminoimidazole-4-carboxamide-1-b-D-ribofuranoside  
AraA: adenine 9-beta-d-arabinofuranoside 
Cmpd C: compound C 
dbcAMP: dibutyryl cAMP 
EtOH: ethanol 
IBMX: 3-isobutyl-1-methylxanthine  
Ncdz: nocodazole 
Pac: paclitaxel 
PBS: phosphate-buffered saline 
PC: palmitoyl carnitine 
Puro: puromycin 
 
 
	   1 
BACKGROUND 
Folliculogenesis and Follicle Structure 
The follicle is the functional small unit of the ovary. Each follicle contains a 
single oocyte, which is enclosed by layers of somatic cells named granulosa cells. The 
oocyte continually exchange metabolite and communicate with this somatic compartment 
via gap junctions, transmembrane channels composed of connexins. Connexins are 
named after their molecular weight. Cx37 is specifically found at the interface between 
oocyte and surrounding somatic cells, while Cx42 is the major type between granulosa 
cells (Veitch et al., 2004).  
It is difficult to understand oocyte behavior without knowing the structure of the 
surrounding environment. A cross section of ovary reveals all types of follicles that are at 
different developmental stages (Figure 1). The more developed the follicle is, the larger it 
becomes. The majority of follicles inside the ovary are primordial follicles. They are very 
small and contain only one layer of flattened granulosa cells. Most primordial follicles 
remain dormant throughout a woman’s reproductive life but small percentage of them 
periodically become activated and grow into primary follicles. Although a primary 
follicle still has one layer of somatic granulosa cells, the size is almost doubled. This is 
mainly due to the change of granulosa shape from flat to cuboidal, the initiation of oocyte 
growth, and formation of zona pellucida that covers the oocyte (Oktem and Urman, 2010). 
A layer of connective tissue, which is called theca, covers the primary follicle. As the 
follicle grows, granulosa cells undergo mitosis and produce up to 6 layers of cells. 
Multiple granulosa layers mark the secondary follicle stage. While most secondary 
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follicles undergo atresia (apoptosis of follicle), a few further develop and become tertiary 
follicles. Up to this point (early secondary stage), it is generally thought that early follicle 
growth is independent of gonadotropin, follicle-stimulating hormone (FSH), since the 
receptor expression level is low in the granulosa cells (Oktay et al., 1997).  
At the late secondary follicle stage, an antral cavity is formed and filled with the 
fluid that is secreted by granulosa cells. Major components of antral fluid are hormones, 
anticoagulants, enzymes and electrolytes. The inner granulosa cells around the oocyte are 
differentiated into cumulus cells, and those lining the follicle wall are called mural 
granulosa cells. Theca cells are also differentiated into theca interna and theca externa. 
Several secondary follicles are recruited during each cycle to further develop into tertiary, 
or Graafian follicles. This stage of growth is dependent on FSH. Graafian follicles have 
accumulated a large amount of antral fluid and become highly vascular in the theca layer. 
Selection of the dominant follicles occurs simultaneously. In the end, only the follicles 
that are sensitized to gonadotropin and have modulated steroidogenic activity are selected, 
while remaining follicles undergo atresia (Oktem and Urman, 2010). Normally only one 
Graafian follicle is selected to ovulate in human as opposed to several in rodents. 
Follicles at this stage are called preovulatory follicles ( Jone and Lopez, 2006; Hutt and 
Abertini, 2007). After ovulation, the ruptured follicle forms the corpus luteum, which 
starts secreting progesterone, but degenerates soon if pregnancy does not occur (Jone and 
Lopez, 2006).  
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Figure 1 Folliculogenesis 
Follicles at different developmental stages. 
http://www.repropedia.org/folliculogenesis  
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Oogenesis 
Unlike spermatogenesis, mammalian oogenesis is a discontinuous process. 
Primordial germ cells (PGC) originate in the epiblast by tissue-specific interactions 
during gastrulation, a process that requires bone morphogenic protein 4 (BMP4) signaling 
(Lawson et al., 1999). After the specification, PGCs migrate into the genital ridge. Germ 
cells, now called oogonia, undergo multiple rounds of proliferation before they enter 
meiosis and arrest at diplotene prophase I stage (Sasaki and Matsui, 2008).  
Oocytes undergo incomplete cytokinesis in the last round of mitosis and remain in 
cluster before birth. Primordial follicles form in an event called cyst breakdown shortly 
after birth, during which the cytoplasmic bridges that link adjacent oocytes are destroyed 
and individual oocytes become enclosed by follicle cells (Tingen et al., 2009; Pepling and 
Spradling, 1998). Primary oocytes within the primordial follicles remain meiotically 
incompetent and arrested at the diplotene prophase I stage. Upon entering puberty, 
selected follicles start to develop, oocytes gradually gain meiotic competence, 
presumably due to the accumulation of maturation promoting factor (MPF), whose major 
components are cyclin B and cyclin-dependent kinase 1 (CDK1) (Mitra and Schultz, 
1996).  
After a surge of luteinizing hormone (LH), the oocyte inside each Graafian 
follicle resumes meiosis. The enlarged nucleus, which is called the germinal vesicle (GV), 
undergoes germinal vesicle breakdown (GVB). With the progression of meiosis, the first 
polar body (PB) is released. Normally, oocytes are ovulated at the PB stage (metaphase 
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II) and where they remain arrested until fertilization occurs (Figure 2). This process (GV-
MII) is referred to as oocyte maturation (Downs, 2010).  
 
 
Figure 2 Overview of Oocyte Maturation 
Meiotically incompetent oocyte gradually grows and acquires meiotic competence inside the 
follicle. After receiving a preovulatory gonadotropin surge, the oocyte resumes meiosis. The nuclear 
envelope (germinal vesicle) breaks down, the first polar body is released, and the oocyte arrests at 
metaphase II until fertilization occurs. Occasionally, oocyte undergoes parthenogenetic activation without 
sperm fertilization. The period from GV stage to formation of first PB is called oocyte maturation. 
Regulation of Meiotic Arrest 
We now have a better understanding of the signaling pathway that maintains 
prophase I arrest. High cAMP level within the oocyte is critical. Oocytes contain the 
constitutively active G-protein coupled receptor, Gpr3, which activates adenylyl cyclase 
(Mehlmann, 2005). cAMP activates protein kinase A (PKA) that suppresses MPF by 
phosphorylating MPF regulators, Wee1B and Cdc25B. The PKA mediated 
phosphorylation of Wee1 is activating, while that of Cdc25B is inhibitory. Active Wee1 
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negatively regulates the MPF component, CDK1. Cdc25B is a phosphatase, which 
removes inhibitory phosphorylation on CDK1. The phosphatase activity of Cdc25b is 
controlled by PKA: once phosphorylated by PKA, Cdc25B becomes inactive; meanwhile 
the phosphorylation of Wee1B by PKA keeps it in active form and blocks the MPF 
activity (Oh et al., 2010; Han et al., 2005). Thus, both phosphorylation events inhibit 
MPF activity (Figure 3), and ultimately, germinal vesicle breakdown is suppressed.  
The somatic compartment within the follicle plays an important role in 
maintaining meiotic arrest. Thus, when a meiotically competent oocyte is released from 
the follicles, it undergoes spontaneous maturation. In oocytes, the cAMP level is 
balanced by its synthesis and degradation, which is controlled by adenylyl cyclase and 
oocyte specific phosphodiesterase (PDE), PDE3A, respectively.  PDE activity is 
negatively regulated by cGMP (Masciarelli et al., 2004) that is produced in granulosa 
cells and transferred into the oocyte to maintain the arrest.  Indeed, the cGMP level drops 
in the oocyte before meiotic resumption (Robinson et al., 2012).It was recently 
demonstrated that cGMP is the somatic compartment inhibitor that passes through the 
gap junctions and enters the oocyte to suppress PDE activity (Norris et al., 2008, 2009). 
In addition to the granulosa cell regulation of oocyte meiotic arrest, the oocyte 
itself can also maintain its arrest by modifying gene expression in granulosa cells (Zhang 
et al., 2010). Oocyte derived paracrine factors (ODPF) such as BMP15, GDF-9 and Fgf8, 
upregulate natriuretic peptide receptor2 (Npr2) guanylate cyclase expression in cumulus 
cells. At the same time, the Npr2 receptor’s ligand, NPPC, is spatially separated and 
highly expressed in the mural granulosa cells. Activation of Npr2 is thought to be a 
critical source of cGMP production in the somatic compartment (Figure 3). 
	   7 
 
Figure 3 Regulation of Oocyte Meiotic Arrest 
Diagram summarizing the control of meiotic arrest in the absence of LH signal. cGMP is mainly produced 
in the somatic compartment by membrane-bound guanylate cyclase, Npr2, which is activated by the ligand, 
NPPC.  In addition, OOPFs also help increase the Npr2 activity.  cGMP diffuses through the gap junction 
and transferred into the oocyte where cGMP inhibits PDE activity. Thus, cAMP level remains elevated and 
maintains meiotic arrest of oocytes (Conti et al., 2012; Downs, 2010; Zhang et al., 2010; Norris et al., 
2010).   
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Regulation of Meiotic Resumption 
 LH initiates the meiotic resumption of oocytes in vivo. LH receptors are located 
on mural granulosa cells and theca cells. According to the current model, there are 
several ways for LH to convey the positive signal to the interior part of the follicle. One 
way is to activate PKA in granulosa cells that promotes secretion of EGF-like peptides. 
EGF-like peptides diffuse to bind receptors that activate the MAPK pathway in granulosa 
cells. The activation of MAPK induces closure of gap junctions (Norris et al., 2008), 
which decreases the amount of cGMP  transferred to the oocyte. At the same time, the 
activation of MAPK exerts an unknown positive stimulus to the oocyte. In addition, LH 
inhibits Npr2 receptor activity and decreases cGMP production (Robinson et al., 2012).  
With less cGMP entering the oocyte, PDE becomes active, and reduces the cAMP level, 
leading to meiotic resumption (Figure 4). 
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Figure 4 Signals for Meiotic Resumption 
Summary of LH, FSH, and EFG-like peptide induced meiotic resumption. LH, FSH promotes 
EGF-like peptide production in the granulosa cells, and the activation of EGFR induces gap junction 
closure by phosphorylation of Cx43, at the same time, hormonal signaling decreases the guanylate cyclase 
activity. With less cGMP being transferred into the oocyte, PDE becomes active and cAMP is broken down 
into AMP. This relieves the inhibition of MPF and leads to meiotic resumption. It should be noted that 
AMPK is also activated by elevated AMP levels and exert a positive influence on GVB.  
Egg Activation 
Binding of sperm triggers oocyte activation. The initial event includes an 
intracellular calcium spike, followed by subsequent repetitive calcium oscillations, 
mainly by activation of the IP3 receptor (Miyazaki et al., 1993). The egg releases cortical 
granules, which contain multiple enzymes that modify the zona pellucida and block 
polyspermy. The oocyte completes meiosis II, extrudes the second polar body and forms 
pronuclei. This entire process is referred to as egg activation.  
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Cytostatic factor (CSF) activity develops during metaphase II arrest. CSF is a 
multiple component complex, which contains MAPK and an anaphase promoting 
complex (APC) inhibitor, early mitotic inhibitor 2 (Emi2).  High CSF activity maintains 
metaphase II arrest by inhibiting APC and keeping MPF activity high. During egg 
activation CSF activity decreases, thus removing the inhibition of APC and driving entry 
into anaphase II (Madgwick and Jones, 2007). 
Some oocytes undergo spontaneous parthenogenetic activation without sperm 
fertilization (Figure 2). There are many contributing factors, such as the tenure of oocyte 
inside the oviduct and oocyte quality. Usually, the longer it is in the oviduct, the easier it 
gets activated (Kubiak, 1989). Genetic composition is another contributing factor. A 
well-known example is the LT/Sv strain of mice, which is genetically predisposed to 
parthenogenetic activation (Eppig et al., 1996). LT/Sv mice show a high incidence of 
ovarian teratomas, as a result of the oocytes that are directly activated and begin 
developing within the follicles. Once GV-stage oocytes are isolated and cultured in vitro, 
those oocytes undergo parthenogenetic activation as well, which is manifested by the 
formation of interphase pronuclei. In addition, mutations in the genes that are involved in 
maintaining MII arrest cause parthenogenetic activation. For instance, oocytes with a 
mutation in the MAPK upstream kinase, Mos, fail to arrest at metaphase II and display a 
spontaneous activation phenotype (Hashimoto et al., 1994). 
Role of AMP-Activated Protein Kinase in Oocyte Maturation 
During meiotic resumption, AMP produced from cAMP degradation is a potential 
activator for AMPK. AMPK is a heterotrimeric energy sensor protein, which contains a 
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catalytic α subunit and regulatory β,γ subunits (Figure 5). There are 2 isoforms for α 
subunit (α1,α2), 2 β subunits and 3 γ subunits. AMPK is activated by elevated 
AMP/ATP ratio and cellular stress (Salt et al., 1998). Phosphorylation of threonine 172 
on the α catalytic subunit is the hallmark of AMPK activation. LKB1 is a tumor 
suppresser and shows an important role in establishing cell polarity, which is one of the 
upstream kinase of AMPK phosphorylation (Nakada et al., 2010; Williams and Brenman, 
2008). In addition, calcium/calmodulin kinase kinase β (CaMKKβ) also activates AMPK 
in response to calcium signaling (Hardie et al., 2012). AMPK maintains cellular energy 
homeostasis by down-regulating energy consuming pathways (eg, protein synthesis) and 
up-regulating the pathways that generate ATP (eg, fatty acid oxidation). Acetyl-CoA 
carboxylase (ACC) is one of the AMPK targets and is phosphorylated upon AMPK 
activation. When ACC is active, it converts acetyl-coA into malonyl-CoA that inhibits 
carnitine palmitoyltransferase-1, an important carrier for transferring fatty-acyl CoA into 
mitochondria. Thus, without the transfer of fatty-acyl CoA into mitochondria, β-
oxidation does not occur. However, when ACC is inhibited by AMPK phosphorylation, 
malonyl CoA levels are decreased, carnitine palmitoyltransferase-1 become active and 
fatty acid oxidation is promoted. (Downs et al., 2009).  In fact, ACC phosphorylation 
level is often used as an indicator for AMPK activity. In addition to regulating energy 
homeostasis, AMPK is also implicated in many processes including cell growth, polarity 
establishment and transcription (Mihaylova and Shaw, 2011). 
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Figure 5 The general role of AMPK in the somatic cells 
   AMPK consists of the catalytic subunit α and two regulatory subunits β and γ.  It is activated by the 
upstream kinase, LKB1, in the response to elevated AMP to ATP ratio. The activation of AMPK regulates 
energy homeostasis, cell growth and the establishment of polarity. In addition, it has a long-term impact on 
transcription as well.  
Our current model of AMPK involvement in meiotic resumption is depicted in 
figure 6. During meiotic arrest, PKA is activated by cAMP, whereas during meiotic 
resumption, accumulation of AMP promotes maturation in mouse oocytes by turning on 
AMPK (Downs et al., 2002). One of the effects of AMPK on meiotic induction could be 
mediated by increasing fatty acid oxidation (Downs et al., 2009; Valsangkar and Downs, 
2013). 
Our lab has previously demonstrated the role of AMP-activated protein kinase 
(AMPK) in mouse oocyte maturation. AMPK is present in the oocyte and the activation 
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of AMPK precedes GVB (Chen et al., 2006; Chen and Downs, 2008). The AMPK 
activator, aminoimidazole carboxamide ribonucleotide (AICAR), induces GVB and the 
inhibitors, compound C and araA, block maturation. Moreover, GVB occurs when 
oocytes are challenged by different kinds of stress that are proven to activate AMPK 
(LaRosa and Downs, 2006). 
 
Figure 6 The proposed model of AMPK involvement in meiotic induction (adapted from Downs et al., 
2002)  
During meiotic arrest, PDE is inactive. Thus, oocytes contain a high level of cAMP that activates 
on PKA, which phosphorylates Wee1B and Cdc25B that prevents activation of MPF (see Figure 3). 
However, during meiotic induction, PDE becomes active and breaks down cAMP into AMP. The elevated 
AMP level activates AMPK, which acts as a positive stimulus to GVB. 
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Methodology - In Vitro Culture Systems 
We use in vitro culture systems to study oocyte maturation. There are three 
different types of in vitro culture systems: (i) preovulatory follicle culture, (ii) cumulus-
enclosed oocyte (CEO) culture and (iii) denuded oocyte (DO) culture (Downs, 2010). 
Follicle culture is close to the physiological condition since the oocyte is in an 
intact functional unit. The oocyte is maintained in meiotic arrest within the follicle during 
the culture in control medium (ie, devoid of inhibitors or stimulants), because the follicle 
provides an inhibitory environment. The preovulatory follicle is responsive to luteinizing 
hormone (LH), follicle stimulating hormone (FSH) and epidermal growth-factor like 
peptides (EGF) (Downs and Chen, 2008; Norris et al., 2010), and the treatment with these 
hormones induces intrafollicular oocyte maturation. 
CEOs are obtained by physically rupturing preovulatory follicles.  However, once 
released from the follicle environment, meiotic arrest cannot be maintained and oocytes 
undergo spontaneous maturation when cultured in control medium.  The inhibitory 
follicle environment can be mimicked in vitro by supplementing the medium with 
compounds that either increase the cAMP level or inhibit PDE activity within the oocyte. 
Commonly used compounds are the cAMP analogue, dibutyryl cAMP (dbcAMP), or the 
PDE inhibitors, 3-isobutyl-1-methylxanthine (IBMX) and milrinone. In vitro-arrested 
CEOs are responsive to FSH and EGF-like peptides but not LH, because LH receptors 
are localized at the mural granulosa cells, which are now uncoupled from CEOs. 
DOs are obtained by removing surrounding cumulus cells. Like CEOs, they 
undergo spontaneous maturation in the medium, supporting the idea that cGMP produced 
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inside the somatic compartment is important for maintaining meiotic arrest. However, 
DOs do not respond to FSH, or EGF-like peptides, due to the fact that the receptors are 
located on the somatic cells (Figure 7). DO culture is often used to test the direct effect of 
a compound on the oocyte without potentially confounding contribution from cumulus or 
mural granulosa cells.  
Since my work was focused on the event after GVB, spontaneous maturation of 
CEO or DO was mostly used for the experiments. The kinetics of GVB is faster in 
spontaneous maturation than meiotic induction. Most of the oocytes undergo GVB within 
1h as opposed to 4-6h in meiotic induction. A well-aligned metaphase I stage can be 
observed at 8h after onset of the culture and extrusion of the PB can be easily observed 
starting at 10h after initiation of the culture. It is therefore a convenient culture system for 
investigating different aspects of oocyte maturation.  
The purpose of my thesis work was to examine the potential role of AMPK in the 
events beyond germinal vesicle breakdown. Herein I demonstrate that AMPK is required 
at several different times during oogenesis. Firstly, AMPK promotes the completion of 
oocyte maturation by accelerating anaphase I onset and first PB formation. Secondly, the 
normal functioning of AMPK depends on spindle microtubule integrity. Finally, AMPK 
suppresses premature oocyte activation by maintaining MAPK activity.  
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Figure 7 In vitro culture system for studying oocyte maturation (adapted from (Downs, 2010) 
Oocytes remain at GV stage in the intact follicles when cultured in the control medium, but 
resume meiosis in response to LH, FSH and EGFs. Once released from the follicles, CEOs undergo 
spontaneous maturation in the medium without meiotic inhibitors. Arrested CEOs respond to FSH, EGFs. 
Similarly, DOs mature spontaneously in the control medium without meiotic inhibitors, but they are 
unresponsive to hormones when maintained arrest the in meiotic inhibitor.
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CHAPTER I: A ROLE OF AMPK THOUGHOUT MEIOTIC 
MATURATION IN THE MOUSE OOCYTE: EVIDENCE FOR 
PROMOTION OF POLAR BODY FORMATION AND 
SUPPRESSION OF PREMATURE ACTIVATION 	  
Summary 
It has been shown that activation of AMPK is involved in the initiation of mouse 
oocyte meiotic resumption. The purpose of this study was to examine the role of AMPK 
in the entire oocyte maturation period after germinal vesicle breakdown. AMPK 
activators greatly promoted the rate and kinetics of polar body formation in both CEOs 
and DOs, whereas the AMPK inhibitors, compound C and Ara A, had opposite effects on 
polar body formation. Moreover, compound C stimulated the premature activation of 
CEOs but not in the DOs. In addition, oocytes isolated from the mice with a shorter 
hormonal priming period were predisposed to spontaneous activation, which can be either 
significantly increased by compound C or eliminated by the AMPK activator, AICAR 
treatment. Immunofluorescent staining showed that active AMPK was associated with 
the condensed chromosomes, spindle poles and the midbody during the maturation period. 
The α1 subunit of AMPK was colocalized with the chromosomes and the meiotic spindle. 
However, there was no specific staining pattern of the α2 subunit. Interestingly, a 
temporal disconnect is observed between the requirement of AMPK activity and its effect 
on PB formation. AMPK activity is required early during the maturation period for 
stimulation of PB.  Altogether, these data suggest that AMPK is involved in the entire 
oocyte maturation period by promoting the formation of first polar body; meanwhile, it 
suppresses premature oocyte activation.
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Introduction 
AMPK is a cellular gauge that is activated by an elevated AMP to ATP ratio. 
Once activated, it turns on energy production and shuts down energy consuming 
processes (Hardie, 2003; Carling, 2004). AMPK consists of one catalytic α subunit and 
two regulatory subunits, β and γ. Notably both isoforms of catalytic subunits, α1 and α2, 
are expressed in the mouse oocytes (Downs et al., 2002). The role of this energy sensor is 
well studied in somatic cells. A small drop in ATP causes relatively big change in AMP 
to ATP ratio, which significantly increases AMPK activity (Mihaylova and Shaw, 2011). 
The activation of AMPK leads to adaptive changes in growth and differentiation. In 
somatic cells, activation of AMPK induces metabolic checkpoint that causes cell cycle 
arrest that is mediated by mammalian target of rapamycin (mTOR) (Gwinn et al., 2008).  
Interestingly, AMPK seems to have the complete opposite effect on mouse oocyte 
meiotic induction. It has been demonstrated in the previous work that activation of 
AMPK precedes GVB and mediates hormone-induced maturation, which is demonstrated 
by increase in phospho-ACC level after FSH treatment and the appearance of active 
AMPK within the germinal vesicle. Blocking AMPK activity with the specific inhibitors, 
compound C and Ara A, inhibits meiotic resumption in both CEOs and DOs (Chen et al., 
2006; Downs and Chen, 2006; Chen and Downs, 2008).  In addition, meiotic resumption 
can also be induced by stress that activate AMPK (LaRosa and Downs, 2006, 2007). 
While a role for AMPK in meiotic induction is well documented, its effect on the 
later maturation period (after GVB) remains unknown. Herein we demonstrate the 
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involvement of AMPK from GVB to metaphase II stage by using pharmacological 
activators or inhibitors of AMPK. To test the effect of AMPK modulators on later 
maturation events, spontaneous maturation system was mainly used instead of meiotic 
induction. Our data suggest that AMPK has a positive stimulation on PB formation and 
suppressive effect on premature activation. This involvement of AMPK is further 
suggested by the association of active AMPK with chromosomes, spindle poles, and 
midbody throughout maturation.
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Materials and Methods 
Oocyte Isolation and Culture Conditions 
 Immature, 19-23-day-old (C57B/6J X SJL/J) F1 mice were used for all 
experiments.  In most experiments, mice were primed with 5 IU equine chorionic 
gonadotropin (eCG) and 2 days later were killed; the ovaries were removed and placed in 
culture medium where cumulus cell-enclosed oocytes were released from the 
preovulatory follicles when poked with sterile needles.  Some experiments utilized 
unprimed mice or mice primed only 1 d.  Denuded oocytes were obtained by passage of 
CEO through mouth-operated small-bore pipets.  Oocytes were washed free of other 
follicular tissue and transferred to plastic tubes containing 1 ml of the appropriate test 
medium.  The culture medium used was Eagle’s minimum essential medium with Earle’s 
salts (GIBCO/Invitrogen; Carlsbad, CA) supplemented with 0.23 mM pyruvate, penicillin, 
streptomycin sulfate and 3 mg/ml crystallized lyophilized bovine serum albumin (ICN 
ImmunoBiologicals, Lisle, IL) and buffered with 26 mM bicarbonate. 
Immunofluorescent Staining 
Staining was performed on oocytes having undergone maturation either in vitro or 
in vivo. For the latter, 2-day-primed mice were administered 5 IU hCG and oocytes were 
retrieved from antral follicles at varying times post-hCG. Oocytes were fixed with 4% 
formaldehyde at 4°C and permeabilized with 0.1% triton in blocking buffer (0.05% 
saponin in PBS, pH 7.4, plus 10% sheep serum) for 30 min. Oocytes were then washed 
free of triton and continuously blocked for another 90 min at room temperature. Oocytes 
were incubated with rabbit primary antibodies (1:100) overnight at 4 °C, washed in 
	   21 
blocking buffer at room temperature, and incubated with FITC-conjugated sheep anti-
rabbit antibody (1:1,000) at room temperature for 1 hr. For experiments involving alpha 
subunit blocking peptide, primary antibodies were incubated for 1 hr at room temperature 
with blocking peptide before adding oocytes for overnight incubation. After washing, 
oocytes were mounted on prewashed slides with vectashield mounting medium 
containing DAPI (Vector Laboratories, Inc., Burlingame, CA), and cover slips were 
sealed with nail polish. 
Confocal Microscopy 
Oocytes were viewed on a laser scanning confocal microscope (Carl Zeiss Co., 
Thornwood, NY) with a 63× objective. During imaging all settings were kept constant, --
that is, laser power, detector gain, amplifier offset, amplifier gain, and pinhole size. 
Digitally recorded images were exported by LSM Examiner (Carl Zeiss Co.). 
Chemicals 
Saponin, dbcAMP, 8-Br-adenosine, adenine-9-b-D-arabinofuranoside (araA), 
sheep serum, and FITC-labeled sheep anti-rabbit antibody were purchased from Sigma 
Chemical Co. (St. Louis, MO). Compound C and AICAR were supplied by Toronto 
Research Chemicals, Inc. (North York, Ontario, Canada). Anti-PT172 antibody was from 
Cell Signaling Technology (Beverly, MA), and anti- PT172, anti-α1, and anti-α2 
blocking peptides were obtained from Santa Cruz Biotech, Inc. (Santa Cruz, CA). Highly 
purified ovine FSH was purchased from the National Hormone and Peptide Program 
(NHPP), NIDDK, and Dr. A.F. Parlow. 
Statistical Analysis 
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Oocyte maturation experiments were repeated at least three times with at least 30 
oocytes per group per experiment. Data are reported as mean percentage GVB±SEM. 
Following arcsin transformation, maturation frequencies were analyzed statistically by 
ANOVA followed by Duncan’s multiple range test. For all statistical analyses, a P-value 
<0.05 was considered significant. 
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Results 
Effects of AMPK Modulators on Polar Body Formation 
Activators. To test the effect of AMPK activators on PB formation, a dose 
response experiment was carried out (Figure 1.1 A).  CEOs were incubated with the 
increasing concentrations of different AMPK activators, 5-aminoimidazole-4-
carboxamide-1-b-D-ribofuranoside (AICAR) or AMP for 16-17h before the formation of 
the first polar body was assessed. AICAR significantly increased the percentage of the 
PB formation by 26% at the most effective dose (0.2mM) tested in vitro. However, it was 
inhibitory on PB formation on the highest dose tested, 1mM. AMP gradually increased 
the PB percentage at all doses. The extent of stimulation within the two treatment groups 
was the same at the most effective concentrations. This suggests that stimulation of 
AMPK by activators promotes the completion of the maturation. 
To test if the increase in PB rate was due to a fast PB formation kinetics, CEOs 
were cultured in either control or 0.2mM AICAR-containing medium, and the presence 
of PB was checked starting at 7h and every 3hours thereafter.  The presence of PB was 
observed neither in control or AICAR-treated group after 7 h of culture. Sixty percent of 
the AICAR-treated oocytes showed PB at 10h, while this number was only 28% in the 
control oocytes and remained lower at the later time points (Figure 1.1 B). When CEOs 
were cultured in 2mM AMP, a similar acceleration of PB formation was observed (data 
not shown). 
To determine if these agents can directly act on the oocyte, similar experiments 
were carried out with DOs. The presence of the PB was assessed 9h after initiation of the 
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culture, due to the faster kinetics in the DOs. As expected, AICAR dose dependently 
promoted PB formation in DOs, with the most effective dose of 0.1 mM and a 50% 
increase in PB rate. The highest dose of AICAR tested (0.5mM) was toxic to the DOs. In 
comparison to CEOs, AMP was ineffective on promoting PB in DOs, which may be 
caused by the impaired intake. We then tested another AMPK activator, 8-Br-adenosine 
(8-Br-Ado), which has been demonstrated to be effective on CEOs (Downs and Chen, 
2006).  The result showed a similar dose dependent increase in PB formation in DOs 
(Figure 1.1 C). In addition, AICAR treatment also significantly increased the PB 
formation kinetics in DOs (Figure 1.1D). This positive effect on DO implies that the 
activators are acting directly on oocyte itself. 
Meiotic resumption in the mouse oocytes can be induced by different stresses that 
activate AMPK (LaRosa and Downs, 2006, 2007). Therefore, we decided to test whether 
stress can also bring about the similar effect on PB formation. An initial heat stress 
experiment was detrimental to oocyte development so we opted to challenge oocytes by 
altering their energy metabolism. Since oocyte maturation is an active process that 
constantly requires ATP, we decided to pulse oocytes in the energy deficient medium for 
short period of time and then followed by recovery in the regular medium. Oocytes were 
treated with 2-D-glucose, whose downstream metabolite, 6-phospho-2-D-Glucose, cannot 
be further utilized in glycolysis to generate ATP, which is one of the known methods of 
activating AMPK. For the experimental group, we incubated DOs in glucose- and 
pyruvate- free medium with 10mM 2-D-glucose for 3 h, and then washed and transferred 
the oocytes into the regular medium. For controls, one group of oocytes was similarly 
treated with the glucose- and pyruvate- free medium in the absence of 2-D-glucose for 
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the initial 3h before transfer to control medium; and another control group was cultured 
continuously in the 2-D-glucose containing medium in the absence of glucose and 
pyruvate for the entire culture period. As shown in figure 1.1E, only the group that was 
pulsed with 2-D-glucose showed an increased percentage of PB formation, whereas 
continuous exposure with 2-D-glucose inhibited the meiotic progression.  
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Figure 1. 1 Effect of AMPK on PB rate and kinetics 
 (A) CEOs were cultured in MEM/BSA for 16-17 hours in the presence of either AMP or AICAR. 
Both dose-dependently promoted polar body formation. (B) Kinetics of polar body formation in CEOs. 
CEOs were either cultured in control or in the medium containing 0.2mM AICAR, and oocytes were 
checked every 3 hours to assess the polar body rate. (C) The effect of AMPK stimulators on DOs. At the 
lower doses, both AICAR and 8-bromoadenosine increased the rate of polar body. No effect was observed 
on AMP. (D) Kinetics of PB rate in DOs. DOs were cultured either in control or 0.1mM AICAR. The 
frequency of polar body in AICAR group was higher at every time points tested. (E) Short term pulsing 
with 2-D-Glucose significantly promoted PB formation. 
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Inhibitors.  Next we tested the effect of AMPK inhibitors on PB formation. 
Consistent with the activator data, treatment with AMPK inhibitors, compound C (Zhou 
et al., 2001)  and Ara A (Henin et al., 1996) , dose dependently inhibited PB formation in 
both CEOs and DOs, with the effect of Ara A less pronounced in DOs.  Interestingly, 
treatment with compound C induced a higher percentage of oocyte activation in CEOs 
(19%) than DOs (9.5%, data not shown), which was never observed with Ara A treatment 
(Figure 1.2 A and B). Activated oocytes displayed a predominant pronucleus and 
underwent limited cleavage after further culture.  
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Figure 1. 2 Effect of AMPK inhibitors on PB formation 
 (A) CEOs and (B) DOs were cultured for 17h in increasing concentrations of compound C 
(0,1,2.5,5µM) and Ara A(0,1,1.5,2 mM). Compound C induced 19% activation of CEOs at 2.5µM.  
Effect of Timing the Exposure to AICAR and Compound C on PB Formation and 
Activation 
In order to determine the window that is susceptible to AMPK activation on PB 
stimulation, the AICAR treatment for CEOs was delayed for 0, 2 or 4h. As shown in 
figure 1.3, delaying AICAR treatment decreased the extent of PB stimulation, suggesting 
an early requirement for AMPK activation on first PB formation.  Consistent with this 
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data, when compound C treatment was delayed, the inhibition of PB extrusion was also 
reduced. When compound C treatment was delayed by 4h, the rate of PB formation was 
not significantly different from the control group. Interestingly, the activation rate 
induced by compound C was not affected by the delayed exposure, which may indicate 
the sensitive window for stimulatory effect of AMPK on PB formation precedes later 
inhibitory effect on oocyte activation. 
 
        
Figure 1. 3 Effect of delaying AICAR or compound C exposure on PB and activation 
 CEOs were treated with 0.2mM AICAR or 2.5 µM compound C 0, 2, or 4h after initiation of 
culture. Percentages of PB and activation were assessed after a total of 16-17h of culture.  
Effects of Hormone Priming on Polar Body Formation and Oocyte Activation 
Normally, mouse follicles grow into preovulatory follicle stages 2 days after 
receiving PMSG injection. We have shown that oocytes isolated from the mice that were 
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injected with PMSG for 1 day (hereafter designated as 1-day primed mice), show a 
significantly higher activation rate than those from 2-day primed mice (Downs, 1990). 
Here, we further analyzed the effect of AMPK modulators on PB formation and egg 
activation. CEOs from unprimed, 1-day primed or 2-day primed mice were cultured for 
21-22 h in control medium or medium containing either 0.2 mM AICAR or 2.5 µM 
compound C. The PB rates in 2-day primed and 1-day primed oocytes were comparable, 
but this number was reduced in CEOs from unprimed mice, suggesting a deficiency in 
meiotic competence. Consistent with the previous findings, the percentages of oocytes 
undergoing spontaneous activation increased as the priming periods decreased, 
confirming a protective effect of priming on spontaneous activation (Downs, 1990). 
AICAR increased PB formation in all three groups and eliminated the spontaneous 
activation in unprimed and 1-day primed groups. Compound C treatment induced 
spontaneous activation in the oocytes from 2-day primed animals and augmented the 
activation rates in 1-day primed and unprimed groups (Figure 1.4 A). Together, these 
data support the idea that activation of AMPK promotes completion of the maturation 
while blocking premature activation.  
 A kinetics experiment was carried out to determine the timing of oocyte activation 
as it relates to PB formation.  CEO from 1-day-primed mice were cultured for varying 
periods of time from 15 h to 24 h in the presence or absence of 2.5 µM compound C and 
assessed for PB formation and activation.  In control oocytes, the percentage of oocytes at 
MII peaked at 18 h (55%) and then declined to 35% at 24 h (Figure. 1.4B).  A similar 
pattern was observed in compound C-treated oocytes, but at reduced rates, with PB 
frequency peaking at 26% and decreasing 6 h later to 9%.  In control oocytes, activation 
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was initiated between 18 and 21 h of culture, at the same time PB number started to 
decrease.  The percentage of activated oocytes at 24 h (17%) was similar to the 20% 
decrease in MII oocytes at this time.  Activation in compound C-treated oocytes was 
initiated as early as 15 h (5%) and increased rapidly thereafter, to 48% at 24 h.  These 
data suggest that a significant portion of the activated oocytes derived from MII-stage 
oocytes. 
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Figure 1. 4 Effect of priming on PB formation and oocyte activation 
 (A) CEO were derived from unprimed mice or mice primed for 1 or 2 days, cultured 21–22 h in 
control medium or medium containing 200 mM AICAR or 2.5 mM compound C (Cmpd C), and assessed 
for polar body formation and activation; (B) CEO from 1-day-primed mice were cultured 15–24 h in either 
the absence (-) or presence (+) of 2.5 mM Cmpd C and assessed every 3h for polar body formation (PB) 
and activation (Act). 
Immunostaining of Active AMPK Throughout Meiotic Maturation 
In order to determine the cellular localization of active AMPK, oocytes were 
isolated at different times post-hCG treatment and stained for antibody against the 
phospho-threonine 172 site on the catalytic α subunit. As shown in figure 1.5, active 
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AMPK was associated with condensed chromosomes after GVB, relocated to spindle 
poles during metaphase I, concentrated in the midbody region during anaphase I and 
appeared at the spindle poles again during metaphase II.  
When we looked at the distribution of AMPK in in vitro matured oocytes, the 
same staining patterns were observed regardless of maturation conditions: (1) 
spontaneous maturation of CEO; and meiotic induction in (2) dbcAMP-arrested DO 
stimulated with AICAR and (3) dbcAMP-arrested CEO stimulated with FSH (Figure 
1.6); these results served to validate our in vitro maturation system.   
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Figure 1. 5 Immunolocalization of active AMPK throughout oocyte maturation 
Oocytes were isolated at varying stages of meiosis after hCG administration to 2-day-primed mice, 
fixed and stained with anti-PT172 antibody for active AMPK (green) and DAPI for chromatin (blue). GVB, 
germinal vesicle breakdown; PM, prometaphase; MI, metaphase I; Ana, anaphase; MII, metaphase II. 
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Figure 1. 6 Localization of active AMPK in maturing oocytes in vivo 
From left to right: oocytes were matured in the following maturation conditions (1) spontaneous 
maturation of CEO; (2) FSH-induced maturation of CEOs; (3) AICAR-induced maturation of DOs. Oocyte 
were fixed and stained with anti-PT172 antibody for active AMPK (green) and DAPI for chromatin (blue). 
GVB, germinal vesicle breakdown; MI, metaphase I; Ana, anaphase; MII, metaphase II. 
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Immunostaining of isoforms of the catalytic subunit of AMPK 
Since there are two different isoforms of alpha catalytic subunit of AMPK in the 
mouse oocytes (Downs et al., 2002), we stained each isoform using specific antibodies. 
There was no discrete staining of the α2 subunit (data not shown), whereas α1 subunit 
showed specific staining with chromosomes after GVB, associated with the spindle at the 
later stages (Figure 1.7). This specific staining was eliminated either by neutralizing 
antibody with blocking peptide or omitting the primary antibody. Blocking peptide for α2 
subunit did not affect the specific spindle staining for α1. Interestingly, this specific 
staining pattern of α1 subunit did not coincide with the active AMPK.  
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Figure 1. 7 Immunolocalization of the alpha 1 catalytic subunit of AMPK 
Oocytes were fixed at varying stages of meiosis following hCG injection to 2-day-primed mice 
and stained with anti- α 1 antibody (green) and DAPI for chromatin (blue). Controls in the bottom row 
were of MI-stage oocytes and were either not exposed to primary antibody or anti- α 1 antibody was first 
treated with α 1 blocking peptide or α 2 blocking peptide. GVB, germinal vesicle breakdown; MI, 
metaphase I; Ana, anaphase; MII, metaphase II. 
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Discussion 
Our data suggest that AMPK is involved in the entire mouse oocyte maturation 
process. Activation of AMPK promotes the completion of maturation and suppresses 
premature egg activation, while inhibition of its activity by AMPK inhibitors, compound 
C and AraA, had opposite effects. Compound C, but not AraA, induced spontaneous 
activation in CEOs and augmented the activation rate in oocytes from 1-day and 
unprimed mice, while AICAR eliminated the activation. Active AMPK associated with 
chromosomes during GVB, spindle poles at metaphase I and II, midbody during anaphase. 
The α1 catalytic subunit is localized with chromosomes and the meiotic spindle 
throughout the maturation period. Altogether, these data indicate a supportive role of 
AMPK in the entire oocyte maturation. 
Previous work from our lab demonstrated activation of AMPK precedes meiotic 
resumption and mediates hormone induced maturation (Chen and Downs, 2008). In this 
study we presented evidence for participation of AMPK in later progression of meiosis to 
metaphase II. AMPK activators, AICAR and AMP, dose dependently promoted the 
frequency and the kinetics of PB formation in CEOs. In fact, this effect of AMPK 
activators on PB formation kinetics is mainly due to the early onset of anaphase I through 
inactivating spindle checkpoint activity (see chapter III for details). Although AMP is 
ineffective in DOs, another activator, 8-Br-Ado, effectively increased PB formation in 
DOs. It is unclear why AMP was ineffective in DOs, but cumulus cells are likely required 
for the regular uptake. Moreover, when oocytes were pulsed with 2-D-Glucose, which is 
known to activate AMPK by depleting ATP (Hurley et al., 2005; Zhu et al., 2005; Park et 
al., 2009; Fujimoto et al., 2009; Pradelli et al., 2010), the PB formation was significantly 
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increased.  It should be noted that although AMPK can also be activated by heat stress, 
which induced meiotic resumption in our previous research (LaRosa and Downs, 2007), 
it was not effective in stimulating PB in our current study. This is expected, since it has 
been demonstrated that heat stress impairs both nuclear and cytoplasmic maturation of 
the oocytes and also impairs later developmental competence (Nabenishi et al., 2012; 
Wang et al., 2009) 
Additional support of the role of AMPK on PB formation was provided by the 
inhibitor data. The rate of PB was suppressed by compound C, but to a lesser extent by 
Ara A in DOs, where the uptake may have been hindered by removing the cumulus cells. 
Compound C treatment induced premature activation of the CEOs, but not as effectively 
in DOs. This is consistent with the previous observation that cumulus cells facilitate 
activation (Miao et al., 2005). In an earlier study it has been shown that longer period of 
hormone priming decreased the susceptibility of oocytes to undergo spontaneous 
activation (Downs, 1990). Therefore, we compared the effects of AMPK modulators on 
oocytes from differently primed animals. We increased the in vitro culture period because 
in vitro aging reduces the ability of oocytes to maintain MPF activity, making them more 
susceptible to spontaneous and induced activation (Fissore et al., 2002). Results showed 
that compound C treatment augmented oocyte susceptibility to activation from 1-day and 
unprimed mice, whereas AICAR eliminated the oocyte activation and promoted the PB 
formation, suggesting a protective role of AMPK on premature oocyte activation. 
It has been characterized that while most oocytes undergo parthenogenetic 
activation after reaching metaphase II stage, some oocytes activate directly from 
metaphase I. The well-known examples are LT/Sv and related strains, which display high 
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percentage of spontaneous activation (Kaufman and Howlett, 1986; Eppig et al., 1996; 
Hirao and Eppig, 1997). To investigate at what stage oocytes become activated after 
compound C treatment, a careful kinetics experiment was conducted on oocytes retrieved 
from 1-day primed mice. Oocytes were cultured in both the presence and absence of 
compound C and the formation of PB and activation rates were assessed. In the control 
group, the presence of PB declined after 18h culture, and the decreased number of PB 
was offset by the increased percentage of pronucleus formation. This piece of data 
indicated that the activated oocytes were derived from metaphase II stage oocytes in the 
control group. However, the same situation did not apply to the compound C-treated 
group, where the percentage of activation was almost 3 times greater than the decrease in 
PB rate. In fact, later immunofluorescent staining of compound C-treated oocytes with 
DAPI and tubulin cauptured a portion of them in an anaphase-like state with condensed 
chromosomes within the PB, but with chromosomes inside the oocyte that had already 
become decondensed (Unpublished data, not shown). This suggested that the activated 
oocytes after compound C treatment originated directly from metaphase I, which is also 
consistent with the fact that majority of the oocytes arrest at metaphase I after the 
compound C treatment (data not shown).  
It is well established that metaphase II arrest in oocytes is maintained by high 
MPF and MAPK activity. Recently, it has also been shown that the inorganic metal, Zinc, 
regulates activity of the APC inhibitor, Emi2, and is a new member of CSF components 
(Bernhardt et al., 2011) . 6-dimethylaminopurine (6-DMAP), a general kinase inhibitor, is 
widely used to activate oocytes in vitro, and the site of its action is mainly on interrupting 
the MPF activity, which is regulated by MAPK (Fan and Sun, 2004; Szollosi et al., 1993; 
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Moses and Masui, 1994). Our data suggest that interrupting AMPK activity in the mouse 
oocytes interferes with the second meiotic arrest point and leads to activation. In fact, a 
later portion of my thesis work determined that AMPK regulates MAPK activity to 
prevent premature activation (Chapter III).  
Interestingly, AMPK activity is required very early during maturation (<4h after 
initiation of the culture) to promote PB, because there was a progressive loss of 
stimulation or inhibition of PB formation when AICAR or compound C treatment was 
delayed. However, oocyte activation induced by compound C treatment was refractory to 
the delayed compound C exposure, at least to the latest delay tested (4h). This suggests 
that targets of AMPK for promoting PB formation and oocyte activation are differ in 
stages during cell cycle progression.  
In fact, AMPK was revealed as an important kinase that knocking down of 
AMPK, impaired Drosophila cell cycle progression (Bettencourt-Dias et al., 2004). 
However, the relationship between AMPK activation and cell cycle progression in the 
somatic cells is opposite to what we have observed in the mouse oocytes. A study by 
Jones et al., (2005) showed that a glucose deficiency in mouse primary embryonic 
fibroblasts caused a AMPK mediated metabolic checkpoint. Furthermore, cells 
expressing constitutively active AMPK α2 subunits arrested at G1/S stage. The same 
observation has been confirmed in variety of cell types (Imamura et al., 2001; Igata et al., 
2005; Motoshima et al., 2006; Baumann et al., 2007; Gwinn et al., 2008; Fogarty and 
Hardie, 2009; Ishii et al., 2009; Zang et al., 2009). The AMPK upstream kinase, LKB1, 
which phosphorylates threonine 172 site on the catalytic α subunit. LKB1 mutation has 
been shown to cause an inherited cancer, Peutz-Jeghers syndrome, in humans, which is 
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characterized by high incidence of cancer (Kyriakis, 2003; Hemminki et al., 1998; Jenne 
et al., 1998). In addition, LKB1 was also implicated in regulating the polarity of 
drosophila embryo and human epithelial cell (Alessi et al., 2006; Lee et al., 2007; 
Mirouse et al., 2007).  Independently, LKB1 was found directly associated with the 
meiotic spindle in the mouse oocytes (Szczepańska and Maleszewski, 2005). It would be 
interesting to know whether AMPK also exerts same effects in mouse oocytes. 
Consistent with the above observations in the somatic cells, AMPK activation 
suppresses GVB in pigs (Mayes et al., 2007), cows  (Tosca et al., 2007; Bilodeau-
Goeseels, S Sasseville et al., 2007), and nemertean worms (Stricker et al., 2010), and it is 
ineffective in inducing meiotic resumption in the rat oocytes (Downs, 2011). Herein, our 
data indicated a stimulatory role of AMPK in mouse oocyte meiotic progression at both 
G2/M and the first polar body extrusion. Mouse oocytes are different form the somatic 
cells in a way that glucose is not the primary energy substance. Instead, oocytes are 
mainly dependent on pyruvate that is supplied by the somatic compartment. Increased 
glucose concentration suppressed GVB, while lowering glucose levels promotes meiotic 
induction, which may relates to AMPK activation (Downs and Mastropolo, 1994; Downs, 
1995).  Thus, the major discrepancy between mouse oocytes and these from other species 
in response to AMPK stimulation might also be due to the differential response to energy 
substrates; at least this is the case in the rat oocytes (Downs, 2011). 
The involvement of AMPK in the entire maturation process is further supported 
by the active AMPK localization. We have previously showed the positive staining of 
active AMPK in the germinal vesicle before oocytes undergo GVB. Here we have shown 
that active AMPK is associated with the chromosomes following GVB, on the spindle 
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poles during metaphase I and metaphase II, and the midbody during anaphase I. This 
localization pattern is identical to that reported in somatic cells (Vazquez-Martin et al., 
2009). Furthermore, active AMPK coincides with numerous other kinases that are 
important in meiotic maturation--for instances, MEK1/2 (Sun et al., 2008), phospho-
protein kinase C delta (Ma and Koch, 2008), aurora kinase (Yao et al., 2004; Shuda et al., 
2009) and polo-like kinase (Wianny et al., 1998; Pahlavan et al., 2000; Tong et al., 2002; 
Fan et al., 2003). Many kinases regulate of spindle microtubule dynamics during mouse 
oocyte maturation. I have examined this potential relationship between AMPK and 
microtubules in chapter II.  
  It was of interest to determine the localization patterns of both α 1 and 2 subunits, 
since both are present in the mouse oocyte (Downs et al., 2002). There was no discrete 
staining pattern of α2 subunit, whereas, the α1 subunit was associated with chromosomes 
initially and with the meiotic spindle thereafter. In contrast, the α2 subunit exhibited 
distinct localization in the somatic cells (Salt et al., 1998).  It is possible that having a 
different pattern is the key to opposite effect on cell cycle progression. These results 
suggest that unlike the situation in somatic cells, α1, and not α2, may play a more 
important role in regulating the maturation of mouse oocytes.  
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Chapter II: PERTURBING MICROTUBLE INTEGRITY BLOCKS 
AMP-ACTIVATED PROTEIN KINASE-INDUCED MEIOTIC 
RESUMPTION IN CULTURED MOUSE OOCYTES 
 
Summary 
 The oocyte meiotic spindle is comprised of microtubules (MTs) that bind 
chromatin and regulate both metaphase plate formation and karyokinesis during meiotic 
maturation; however, little is known about the role of MTs in meiosis reinitiation.  This 
study was conducted to determine if microtubule (MT) integrity is required for meiotic 
induction and how it impacts activation of AMP-activated protein kinase (AMPK), an 
important participant in the meiotic induction process.  Treatment with microtubule-
disrupting agents nocodazole and vinblastine dose-dependently suppressed meiotic 
resumption in both arrested cumulus cell-enclosed oocytes (CEOs) stimulated with FSH 
and arrested denuded oocytes (DOs) stimulated with the AMPK activator, AICAR.  This 
coincided with suppression of AMPK activation as determined by western blotting and 
germinal vesicle immunostaining.  Treatment with the MT stabilizer paclitaxol also 
suppressed meiotic induction.  Targeting actin filament polymerization had only a 
marginal effect on meiotic induction.  Immunolocalization experiments revealed that 
active AMPK colocalized with gamma tubulin during metaphase I and II, while it 
localized at the spindle midzone during anaphase. This discrete localization pattern was 
dependent on MT integrity.  Treatment with nocodazole led to disruption of proper 
spindle pole localization of active AMPK, while paclitaxel induced excessive 
polymerization of spindle MT and formation of ectopic asters with accentuated AMPK 
colocalization.  Although oocytes stimulated by AMPK activator increased the rate of 
	   45 
GVB, spindle formation and PB extrusion, blocking AMPK activity did not influence 
peripheral movement of the spindle.  These data suggest that the meiosis-inducing action 
and localization of AMPK are regulated by MT spindle integrity during mouse oocyte 
maturation. 
	   46 
Introduction 
 Mammalian oocyte maturation refers to the developmental period between 
germinal vesicle breakdown and formation of the first polar body and involves dynamic 
changes within the cytoskeletal network.  Initially, the meiotic spindle forms at a position 
slightly off-center, where the germinal vesicle (GV) was originally located.  After 
germinal vesicle breakdown (GVB), microtubules start polymerizing around the 
condensing chromosomes, and as the chromosomes congress a bipolar metaphase I 
spindle is established, with chromosomes correctly aligned at the metaphase plate. 
Meiotic spindle migration occurs after its formation and this process relies on a dynamic 
microfilament meshwork (Azoury et al., 2008), actin filament nucleator, Formin-2 
(Dumont et al., 2007), and RhoGTPase  (Na and Zernicka-Goetz, 2006). The peripheral 
spindle migration is a crucial process that assures conservation of ooplasm through 
asymmetrical cell division of the polar body.    
 The meiotic spindle association of AMPK is intriguing, because numerous 
proteins showing a similar localization pattern are known to regulate meiotic spindle 
assembly and function; AMPK has also been shown to have a role in maintenance of 
genome integrity and establishment of cell polarity in Drosophila embryos and other 
somatic cells (see Discussion). It is well understood that normal cytoskeleton function is 
required for later oocyte maturation processes, since it was directly related to spindle 
positioning, chromosome segregation. However, less is known about the role of the 
cytoskeleton requirement on meiotic induction.  So it was of interest to test how 
microtubule and spindle integrity was related to AMPK function in mouse oocytes.
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Specifically, we are interested in answering two questions; 1) how does perturbation of 
the microtubule integrity affect AMPK mediated meiotic induction in mouse oocytes? 2) 
And what is the relation between AMPK and spindle microtubule integrity?  Our data 
indicate that disruption of microtubule integrity blocks hormone-induced maturation in 
meiotically arrested oocytes while coincidentally blocking AMPK activity.  Moreover, 
active AMPK colocalization with γ-tubulin at microtubule organization centers (MTOC) 
during metaphase I and II is dependent on spindle integrity.  However, treatment of 
oocytes with AMPK inhibitor did not prevent spindle formation, despite suppressing the 
completion of meiotic maturation.  
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Materials and Methods 
Oocyte Isolation and Culture Condition 
 All procedures were approved by the Marquette University Institutional Animal 
Care and Use Committee.  Immature, 19-23-day-old (C57B/ 6J✕ SJL/J) F1 female mice 
were used for all experiments. Mice were primed with 5IU pregnant mare serum 
gonadotropin (PMSG) 2 days before the experiments. Mice were killed by cervical 
dislocation and ovaries were removed and placed in the petri dish containing culture 
medium.  CEOs were isolated by puncturing the follicles with sterile needles.  DOs were 
obtained by stripping cumulus cell by using mouth operated small-bore pipette.  Both 
CEOs and DOs were washed twice and transferred to plastic culture tubes containing 1ml 
of the appropriate test medium.  The culture medium used was Eagle minimum essential 
medium (Sigma, St Louis, MO) supplemented with penicillin, streptomycin sulfate, 
0.23mM sodium pyruvate and 3mg/ml bovine serum albumin (MP Biomedicals, Solon, 
OH).  
Immunofluorescent Staining 
 Oocytes were fixed with microtubule stabilizing buffer as previously described 
(Messinger and Albertini, 1991)  at 4°C overnight.  Oocytes were permeabilized 30 min 
with 0.1% triton-100 in blocking solution, which contained 10% donkey serum and 0.5 
mg/ml saponin in PBS, followed by 1h in blocking solution minus triton-100.  Oocytes 
were incubated with antibody recognizing active AMPK (1:100) overnight at 4°C, and 
washed 4 times at room temperature in blocking buffer.  Oocytes were coincubated with 
FITC-conjugated anti-α-tubulin antibody (1:100) and Cy3-conjugated secondary antibody 
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(1:100) 1h at room temperature.  After washing, oocytes were placed at slides and 
mounted with medium containing DAPI (Vector Laboratories, Burlingame, CA). 
Confocal Microscopy 
 Oocytes were viewed on laser scanning confocal microscope (Carl Zeiss Co., 
Thornwood, NY) with a 63X objective.  During scanning, all settings were kept constant: 
i.e., laser power, detector gain, amplifier offset, amplifier gain, and pinhole size.  
Digitally recorded images were exported by LSM Examiner software (Carl Zeiss Co.).  
Western Blot Analysis 
 Oocytes samples were washed with PBS/PVP, then twice with the protease 
inhibitor cocktail (Roche, Indianapolis, IN).  Samples were treated with Laemmli’s 
Buffer with 20% beta-mercaptoethanol at 95°C for 5 minutes.  Electrophoresis was 
carried out using NuPAGE 3-8% Tris-Acetate Gels (Invitrogen, Carlsbad, CA), and 
proteins were transferred to nitrocellulose.  Membranes were blocked with 5% non-fat 
milk, followed by incubation with primary antibody pACC (1:250, Cell Signaling) at 4°C 
overnight.  Blots were rinsed with TBS (pH 7.4) and TBS-Tween-20 (0.05%), and 
incubated with HRP-conjugated goat anti-rabbit antibody (1:2000 in 5% non-fat milk, 
Pierce) at room temperature for 60 min. After washing, protein signals were detected by 
Super Signal West Pico Chemiluminescent Substrate (Pierce). Blots were stripped with 
Restore Western Blot Stripping Buffer (Thermo Scientific; Rockford, IL) and reprobed 
with anti-ACC1 antibody (1:250; Cell signaling) as a loading control.  pACC/ACC1 ratio 
was quantified with ImageJ software based on protein band density. 
Chemicals 
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 Saponin, dbcAMP, donkey serum, nocodazole, vinblastine, paclitaxel and FITC-
labeled mouse anti-α tubulin were purchased from Sigma-Aldrich Co. (St. Louis, MO).  
Cy3-conjugated donkey anti-rabbit antibody was supplied by Jackson ImmmoResearch 
(West Grove, PA).  AICAR and compound C were obtained from Toronto Research 
Chemicals, Inc. (North York, Ontario, Canada).  Anti-phospho AMPK (PT172) antibody 
was purchased from Cell Signaling Technology (Beverly, MA).  Highly purified ovine 
FSH was from the National Hormone and Peptide Program (NHPP) and Dr. A.F. Parlow. 
Statistical Analysis 
 All experiments were repeated at least three times and data presented as mean ± 
SEM.  Percentages of GVB or nuclear stain underwent arcsin transformation and data 
were analyzed statistically by ANOVA followed by Duncan’s multiple range test.  A P-
value <0.05 was considered significant.
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Results 
Effect of Cytoskeletal Disrupting Agents on Maturation and AMPK Activity 
 We have shown that AMPK is involved in hormone-induced maturation and its 
activation precedes GVB in mouse oocytes (Chen and Downs, 2008). We therefore 
determined how perturbing microtubule integrity would affect AMPK activity and 
meiotic induction.  dbcAMP-arrested CEOs were treated with 0.1µg/ml FSH to induce 
meiotic resumption, exposed to increasing concentrations of  nocodazole, and assessed 
for GVB after 17-18 h.  As shown in Figure 2.1A, FSH increased the percentage of GVB 
by 62%, while supplementation with nocodazole significantly blocked this increase in a 
dose-dependent manner, by 62% at the highest dose tested.  DMSO alone, the nocodazole 
vehicle, had no effect on meiotic resumption (data not presented).  To test for a direct 
effect of nocodazole on the oocyte, dbcAMP-arrested DOs were treated with 250µM 
AICAR, an AMPK activator, and scored for GVB. AICAR stimulated an increase in 
GVB from 23% to 89%. This stimulation was abolished by nocodazole, which 
significantly decreased the percentage of maturation to 8% (Figure 2.1B).  This inhibition 
was completely reversible, thereby demonstrating that the drug did not act through toxic 
means. 
 FSH-treated CEOs were cultured for 4 h and AICAR-treated DOs were cultured 
for 2.5 h before fixation and immunofluorescent staining for active AMPK, using an 
antibody against phospho-threonine 172 on the alpha catalytic subunit of AMPK.  As 
previously shown, FSH and AICAR increased phospho-AMPK staining in the germinal 
vesicle prior to GVB.  This staining pattern is characterized by homogeneous staining 
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throughout the germinal vesicle with absence of label within nucleoli (Chen and Downs, 
2008).  Since nocodazole blocked AICAR- and FSH-induced GVB, it was important to 
determine if this GV staining pattern was present after nocodazole treatment of these 
oocytes.  As shown in Figure 2.1C, 21% of control CEOs arrested in dbcAMP showed 
nuclear staining, with a 20% increase following FSH treatment, and exposure to 10 µg/ml 
nocodazole eliminated this increase.  A similar pattern was evident in DOs: GV staining 
was detected in 26% of control oocytes, with this number increasing to 57% after culture 
in AICAR, and nocodazole again prevented the response (20% with active AMPK 
accumulation in the GV; Figure. 2.1D).  These data support the idea that activity of 
AMPK is greatly influenced by microtubule integrity.  This was confirmed by western 
blot analysis of nocodazole-treated oocytes that showed suppression of AICAR-induced 
AMPK activity, using phospho-acetyl CoA carboxylase as a marker for AMPK activity 
(Figure 2.1E, F). 
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Figure 2. 1 Effects of nocodazole treatment on meiotic resumption and AMPK activation 
 (A) CEOs were cultured in medium containing 300 µM dbcAMP (dbc) plus FSH in the 
presence of increasing concentrations of nocodazole.  Germinal vesicle breakdown (GVB) was assessed 
17-18h later.  (B) DOs were cultured with 300 µM dbcAMP plus 250 µM AICAR and treated with 
increasing doses of nocodazole.  GVB was assessed after 4h of culture.  (C) CEOs were cultured in 300 
µM dbcAMP alone (control) or dbcAMP plus FSH with or without 10 µg/ml nocodazole; 4h later 
oocytes were fixed and processed for PT172 staining.  (D) DOs were cultured for 2.5 h in the same 
medium as CEOs but with FSH replaced by 250 µM AICAR; oocytes were then processed for PT172 
staining.  In both C and D, nocodazole reduced the frequency of the GV stain to control levels.  (E) 
Western blot analysis of pACC of oocytes that were treated as described in B; ACC1 was used as 
loading control. (F) Quantification of pACC and ACC1 from western blot.  pACC and ACC1 ratio were 
normalized to the control dbcAMP-treated group.  Groups with no common letter are significantly 
different. 
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When CEOs were treated with another microtubule-destabilizing agent, 
vinblastine, meiotic induction was again suppressed, with a 31% decrease at the highest 
concentration tested (Figure 2.2A).  Inhibition was even more robust in AICAR-treated 
DOs, with 20µg/ml vinblastine reducing the maturation percentage to control levels 
(Figure 2.2B).  
 To test how stabilizing microtubules affects the meiotic induction, the 
microtubule-stabilizing agent, paclitaxel was utilized.  CEOs were cultured 17-18h and 
treated with FSH plus increasing doses of paclitaxel. Similar to the finding with 
microtubule disrupting agents, FSH-induced GVB was blocked in dose-dependent 
fashion by paclitaxel (Figure 2.2C), and the agent was even more potent in AICAR-
treated DOs (Figure 2.2D).  When FSH- and paclitaxel-treated oocytes were fixed after  4 
h and stained with anti-PT172 antibody, no label was observed in the GV; however, 
punctate staining was present throughout the cytoplasm (data not shown).  When 
paclitaxel was added to AICAR-treated DOs, punctate staining of active AMPK was 
observed near or within the GV, but with no homogeneous staining within the GV. The 
increased punctate staining of active AMPK after paclitaxel treatment may correspond to 
excessive stabilization of microtubule polymers.  
 To determine whether inhibiting actin filament polymerization plays a role in 
meiotic induction, cytochalasin D and latrunculin A were added to either FSH-stimulated 
CEO cultures or AICAR- stimulated DO cultures. There was no effect of cytochalasin D 
on GVB.  Latrunculin A showed a modest reduction (29%) of GVB in FSH-treated CEOs 
(Figure. 2.2E), but it was toxic to AICAR-treated DOs.  
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We decided to test if activating the AMPK downstream pathway, fatty acid 
oxidation, would bypass the inhibitory effect of nocodazole on meiotic induction. 
Palmitoyl carnitine, the fatty acid derivative that was shown to induce maturation by 
increasing fatty acid oxidation, was added to the CEO culture (Downs et al., 2009). 
Consistent with the early findings, nocodazole blocked FSH-induced maturation in CEOs; 
however, direct stimulation of fatty acid oxidation by palmitoyl acid significantly 
reversed this inhibition (Figure 2.2F). These data indicate that the fatty acid oxidation 
pathway is still active during microtubule depolymerization, suggesting nocodazole 
treatment does not cause a generalized toxicity in the oocytes. 
 
 
 
 
 
 
 
 
 
	   56 
 
Figure 2. 2 Effect of additional microtubule-targeted agents on FSH- and AICAR-induced 
maturation in vitro 
(A, C) CEOs were cultured 17-18 h in medium containing 300 µM dbcAMP plus FSH or (B, D) 
DOs were cultured 4 h in 300 µM dbcAMP plus 250 µM AICAR, in the presence of increasing 
concentrations of vinblastine (A, B) or paclitaxel (C, D).   (E) CEOs were cultured 17-18 h in 300 µM 
dbcAMP plus FSH and increasing concentrations of latrunculin A before GVB assessment.  (F) 
dbcAMP-arrested CEOs were induced to undergo maturation with FSH, and this stimulation was 
suppressed by further treatment with nocodazole. Palmitoyl carnitine (50 µM) was added to the latter 
group to trigger GVB via activation of fatty acid oxidation.  Groups with no common letter are 
significantly different.   
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Association of Active AMPK with Microtubules and Effect of Microtubule Perturbants on 
Localization 
 Since studies in other labs have demonstrated that the meiotic spindle-associated 
localization of numerous proteins is dependent on MT integrity, the next series of 
experiments were conducted to confirm this relationship for AMPK.  Oocytes undergoing 
in vivo maturation were fixed 8 h after human chorionic gonadotropin (hCG) injection to 
obtain metaphase I-stage oocytes and stained with antibodies to active AMPK and γ-
tubulin.  As expected, AMPK colocalized with γ-tubulin at the spindle poles during MI 
(Figure. 2.3A).  
 To test if active AMPK localization is dependent on spindle microtubule integrity, 
microtubule-targeted agents were tested on CEOs during in vitro culture.  Isolated CEOs 
were arrested in 300µM dibutyryl cAMP (dbcAMP) and then treated with 0.1 µg/ml FSH 
to induce maturation.  CEOs were cultured for 17 h before addition of the microtubule-
depolymerization agent, nocodazole (0.05 µg/ml), or the microtubule-stabilizing agent, 
paclitaxel (20 µM), and oocytes were fixed 1 h later and stained for active AMPK and α-
tubulin.  Nocodazole depolymerized the spindle, and as a result, chromosomes became 
scattered and, not surprisingly, normal spindle pole localization of active AMPK was 
disrupted (Figure. 2.3B).  When oocytes were treated with paclitaxel, microtubules were 
excessively polymerized and spindles were larger than normal; formation of a double 
meiotic spindle was occasionally observed, with 2 points of active AMPK localization at 
each pole.  Many small asters also appeared in the cytoplasm with colocalized AMPK 
(Figure 2.3B).  To test whether reestablishment of a bipolar spindle could bring active 
AMPK localization back to its normal localization, in-vitro matured MII-stage CEOs 
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were subjected to nocodazole (5 µg/ml) for 10 minutes; the nocodazole was then washed 
out and oocytes were allowed to recover for 1 h to allow reformation of a bipolar MII 
spindle before fixation and processing for immunoflorescent staining.  The MII spindle 
completely disappeared after 10 min treatment with nocodazole, and active AMPK was 
randomly dispersed as before (data not shown).  Upon spindle repolymerization, active 
AMPK localization returned to the spindle poles (Figure 2.3B), thereby demonstrating 
reversibility of the nocodazole effect and a microtubule-dependent localization of active 
AMPK in mouse oocytes. 
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Figure 2. 3 Immunofluorescent staining of active AMPK and tubulin 
 (A) Oocytes were collected 8 h after administration of hCG to PMSG-primed mice to obtain 
oocytes at MI.  Active AMPK (green) is colocalized at the spindle poles with g-tubulin (red).  Chromatin, 
blue.  INSET: MI spindle from triple-stained oocyte showing a-tubulin, green; active AMPK, red; 
chromatin, blue.  (B) Effect of microtubule-targeted agents on active AMPK localization.  CEOs were 
cultured 17 h in the presence of 300 µM dbcAMP plus FSH; then either the microtubule-destabilizing agent, 
nocodazole (Ncdz, 0.05 µg/ml), or microtubule-stabilizing agent, paclitaxel (Pac, 20 µM), was added and 
oocytes were fixed 1h later and processed for immunostaining for active AMPK (PT172, red) and a-tubulin 
(green).  Nocodazole treatment disrupted the normal spindle pole localization of active AMPK.  When 
treated with paclitaxel, microtubules were excessively polymerized, and this was associated with increased 
AMPK staining.  After CEOs were cultured 17 h in the presence of 300 µM dbcAMP plus FSH, oocytes 
were exposed to nocodazole (5 µg/ml) for 10 min.  The nocodazole was then washed out and oocytes were 
allowed to recover for 1h before fixation and immunostaining.  Upon microtubule repolymerization, active 
AMPK reestablished its normal spindle pole localization.  Red, active AMPK; green, α –tubulin; blue, 
chromatin. Scale bar, 50 µm. 
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Effect of AMPK Modulators on Cytoskeleton Dynamics  
 Our data suggest microtubule integrity is critical for localization and activity of 
AMPK.  We next tested if the reverse regulation was true; that is, if AMPK regulates 
spindle dynamics.  AMPK stimulators, AICAR, AMP and 8-Br-adenosine accelerate PB 
formation of spontaneously maturing CEOs (Downs et al., 2010), and it is possible that 
this is mediated by accelerated spindle formation.  First, CEOs were matured 
spontaneously in MEM/BSA control medium in the presence or absence of 200 µM 
AICAR and the kinetics of GVB were determined.  After 45 minutes of AICAR 
treatment, the percentage of GVB was increased from 35% to 52%; thereafter, maturation 
percentages were comparable up to105 min of culture (Figure. 2.4A).  To examine the 
impact of AICAR on spindle formation, CEOs that were cultured in the presence or 
absence of AICAR were fixed at discrete time points and processed for α-tubulin 
immunofluorescent staining.  Polymerization of microtubules into a barrel-shaped spindle 
was the criterion used for assessment. AICAR significantly fastened spindle formation at 
the early time point (an increase from 12% to 24% at 3 h), which is roughly 1 hour after 
GVB (Figure. 2.4B). This trend toward increased spindle formation in AICAR-treated 
oocytes continued for the next 2 h, but differences were not significant.  
 Spindle migration is important for asymmetric cell division in oocytes, which 
helps minimize loss of cytoplasm during polar body extrusion.  We determined whether 
blocking AMPK activity could influence the migration of the meiotic spindle.  
Spontaneously maturing CEOs were supplemented with the AMPK inhibitor, compound 
C, and position of the spindle was checked at 8,12 and 16 h after initiation of culture.  
Spindles were considered to have migrated to the periphery if they were located more 
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than one-half the radius of the oocyte from its center. As shown in Figure 2.4C, by 8h 
culture 79% of the control oocytes had a peripherally-located spindle; this number was 68% 
in compound C-treated oocytes, which was not significantly different from controls. By 
16 h, most CEOs in control medium had released the first polar body and 95% of the 
oocyte spindles were peripherally localized. The supplementation of compound C 
significantly blocked PB formation, but did not interfere with the peripheral movement of 
the spindle.     
 Finally, we tested whether inhibition of AMPK activity would perturb actin 
microfilament dynamics, especially the polymerization status of the cortical region.  
Extensive actin polymerization occurs in the cortical area and facilitates attachment of the 
outer-most spindle pole to the cortex (Azoury et al., 2008). When CEOs were cultured in 
control MEM or medium containing 2.5 µM compound C for 9.5 h and 11.5 h and 
processed for phalloidin staining, normal F actin polymerization was observed in both 
groups (data not shown).  Thus, compound C treatment did not interfere with polar body 
formation by blocking actin microfilament polymerization.  
 
 
 
 
 
 
 
 
	   62 
 
Figure 2. 4 Effect of AMPK modulators on spontaneous maturation, early spindle formation and 
spindle periphery movement 
 (A) Effect of AMPK activator, AICAR, on spontaneous maturation.  CEOs were cultured in 
control MEM or medium supplemented with 250 µM AICAR, and percentage of GVB was checked at 
45, 75 and 105 min after initiation of the culture.  (B) Effect of AICAR on early spindle formation. 
CEOs were cultured in MEM or MEM plus 250 µM AICAR for 3, 4, and 5 h before spindle formation 
was assessed by immunofluorescent staining.  (C) Effect of the AMPK inhibitor, compound C, on 
spindle periphery movement.  CEOs were cultured in control medium or medium containing 2.5 µM 
compound C.  Spindle periphery movement was examined at the indicated time points. An asterisk 
denotes a significant difference from the corresponding control.   
 
!
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Discussion 
 In this study, we show that perturbing microtubule integrity in mouse oocytes 
reversibly interferes with meiotic induction of CEOs by FSH and DOs by AICAR, which 
is accompanied by the loss of AMPK activity.  It also disrupts the normal localization of 
active AMPK during maturation. On the other hand, microfilament perturbants had little 
effect on maturation.  While AMPK stimulation accelerated both GVB and spindle 
formation, blocking its activity with compound C did not affect actin polymerization or 
interfere with peripheral spindle migration, though karyokinesis was suppressed.  
 Disruption of microtubules with nocodazole and vinblastine, as well as their 
stabilization with paclitaxel, blocked both AICAR-induced maturation in DO and FSH-
induced maturation in CEO.  This was associated with suppression of AMPK activation, 
as determined by Western blotting of phospho-ACC as well as loss of pAMPK staining in 
the germinal vesicle that occurs prior to meiotic resumption (Chen and Downs, 2008). 
Compartmentalization is one of the many ways of controlling signal transduction and cell 
cycle (Pines, 1999). Best-known examples in oocyte meiosis are MPF and its two 
regulatory components Cdc25B and Wee1. MPF is more concentrated in the cytoplasm 
during GV arrest, whereas both Cdc25B phosphatase and MPF adopt nuclear localization 
shortly before GVB, where Cdc25B keeps MPF activated; at the same time, Wee1 is 
exported from the nucleus to relieve the inhibition on MPF (Oh et al., 2010). MAPK, 
which is required for GVB, also translocates to the germinal vesicle just before GVB in 
the pig oocytes (Inoue et al., 1998). That nocodazole and paclitaxel suppressed GV 
staining of pAMPK in FSH- and AICAR-treated oocytes, coincident with a reduction in 
meiotic resumption, suggests a microtubule-dependent step within the oocyte in AMPK 
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regulation of meiosis that involves nuclear localization. Nuclear transport is gated by the 
pore complexes that span the nuclear membrane (Adams and Wente, 2013; Stewart, 
2007). Cytoskeleton is required for successful nuclear imports of some proteins, such as 
p53 and parathyroid hormone-related protein (Salman et al., 2005; Rathinasamy and 
Panda, 2008; Giannakakou et al., 2000; Lam et al., 2002). It has been proposed that MPF 
is translocated to the periphery of the nucleus by microtubule dependent transport before 
it is imported into the nucleus, and this is thought to be critical for meiotic resumption 
(Van-Blerkom, 1991; Albertini, 1992).  Perhaps a similar mechanism applies for AMPK 
even though we cannot rule out the possibility that disrupting microtubule dynamics 
interferes with the regular special organization of other proteins that help to drive meiotic 
resumption in response to FSH and AICAR. Consistent with this idea, nocodazole- 
suppressed AMPK activity, as assessed by western analysis. 
  Nocodazole was shown to block GVB in spontaneously maturing rat oocytes 
(Albertini, 1987), but we did not observe a similar inhibitory action on spontaneously 
maturing mouse oocytes (data not shown), results consistent with those of others 
(Wassarman et al., 1976; Van-Blerkom and Bell, 1986). Supplementation with taxol also 
did not affect the GVB of spontaneously maturing mouse oocytes (data not shown) and 
this has been shown by others for both rat and mouse oocytes; however, like the effects 
with nocodazole, taxol impairs later meiotic progression, resulting in failure of 
karyokinesis in mouse oocytes (Albertini, 1987; Combelles and Albertini, 2001). These 
distinct effects of microtubule perturbants provide another piece of evidence on the 
differences between the two species regarding meiotic regulation (cf, Downs, 2011). In 
addition, these data suggest that the differences exist between spontaneous maturation 
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and meiotic induction of the oocytes, the latter is more sensitive to perturbation of the 
microtubule integrity.  
 In a previous study (Downs et al, 2010), we demonstrated that active AMPK 
associates with chromosomes after GVB, localizes to the spindle pole during Metaphase I 
and II, and moves to the spindle midzone during anaphase.  Here we show that active 
AMPK colocalizes with γ-tubulin, indicating an association with spindle organizing 
centers during formation of metaphase I spindles.  This distribution pattern of pAMPK 
during oocyte maturation is similar to that occurring during mitosis of somatic cells 
(Vazquez-Martin et al, 2009) and is consistent with a reported role for AMPK in cell 
cycle progression (Bettencourt-Dias et al., 2004; Alessi et al., 2006; Koh and Chung, 
2007; Williams and Brenman, 2008). The translocation of AMPK throughout maturation 
suggests a dynamic process at work. The poleward transport of active AMPK might be 
dependent on the minus-end directed motor protein, dynein, which has been shown to be 
critical for spindle pole transport of proteins such as NuMA and Eg5 (Merdes et al., 2000; 
Uteng et al., 2008). 
 Since AMPK shows a close association with microtubule containing structures, it 
is not surprising that perturbation of microtubules dramatically affected the localization 
of AMPK within the oocyte.  Nocodazole destruction of spindle structure led to dispersal 
of active AMPK in a punctate staining pattern that coincided with staining of microtubule 
asters, indicating that the localization pattern of active AMPK is dependent on the 
integrity of the meiotic spindle and presence of microtubule organizing centers (MTOCs).  
Mouse oocytes have multiple acentriolar MTOCs that can be grouped into two subsets: 
one is associated with the meiotic spindle and the other is cortical (Maro et al., 1985; 
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Schatten et al., 1986; Messinger and Albertini, 1991).  Active AMPK was associated with 
both types of MTOCs. Active AMPK is more concentrated around MTOCs that is 
associated with spindle, since stabilization of microtubules with paclitaxel treatment 
induced further accumulation of AMPK at MTOCs and enlarged spindles.  
 As discussed in the previous chapter, the upstream kinase of AMPK, LKB1, is 
implicated in establishing the cell polarity in numerous types of cells including mouse 
oocytes (Zhang et al., 2008; Mirouse et al., 2007; Bonaccorsi et al., 2007; Szczepańska 
and Maleszewski, 2005). Thus, it was of interest to test whether AMPK is also involved 
in a similar capacity in mouse oocytes.  In oocytes, the spindle forms at the center of the 
oocyte after GVB, and then migrates toward the oocyte periphery where the PB is 
extruded, a process crucial to asymmetric cell division and differentiation of cortex into a 
cortical granule-free domain (Sun and Schatten, 2006). 
 Inhibiting AMPK activity in spontaneously maturing CEO with compound C did 
not perturb the peripheral movement of the spindle.  Though some recent studies also 
suggest the participation of microtubules (Ai et al., 2008), spindle movement in the 
oocyte is known to be highly dependent on a dense actin microfilament meshwork 
(Azoury et al, 2008).  Our results suggest that interfering with AMPK activity does not 
affect the integrity of the cortical actin network, because the extensive F actin 
polymerization in the cortex near the spindle appeared unperturbed by compound C 
treatment.  Myosin regulatory light chain (MRLC) is an important component of myosin 
II that participates in actomyosin-mediated cytokinesis at the cleavage furrow (Dumont et 
al., 2007),  and becomes phosphorylated in somatic cells in response to AMPK activation 
(Lee et al, 2007).  However, it is unclear whether MRLC is a physiological substrate for 
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AMPK under energy depleted conditions (Bultot et al., 2009).  It will be interesting to 
determine if AMPK influences the interaction of actin and myosin at the time of 
cytokinesis. 
As we discovered in the previous chapter, AMPK activators accelerate the 
kinetics of the first polar body formation, which is likely due to the positive effect of 
AMPK activation during the early meiotic events. Here we show that both spontaneous 
GVB and the meiotic spindle formation rates are increased by AICAR treatment, which 
indicate that AMPK manifests an early effect during maturation to shorten the overall 
maturation time. This is consistent with the previous finding that AICAR is required 
within 4h after the initiation of the culture to promote later polar body formation. 
Although we observed a positive effect of AICAR treatment on spindle formation, it is 
likely simply due to the accelerated kinetics of GVB.   
 Numerous proteins exhibit a similar localization pattern and have important roles 
in spindle organization and function.  For instance, aurora-A kinase induces GVB in 
Xenopus oocyte and has to be dephosphorylated for the MI-MII transition (Ma et al., 
2003). In mouse oocytes, aurora-A is critical for spindle assembly, centrosome 
maturation and chromosome segregation.  Furthermore, its role is not limited to oocyte 
maturation, as it also contributes to early embryo spindle organization (Yao et al., 2004; 
Ding et al., 2011). Another aurora kinase family member, Aurora-B, is one of the 
chromosome passenger proteins and specifically localizes to the metaphase chromosomes, 
where it mediates chromosome segregation and spindle kinetochore attachment 
(Uzbekova et al., 2008; Shuda et al., 2009).  Aurora C kinase localization is similar to 
that of active AMPK; moreover, injection of deficient kinase induced failure of 
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cytokinesis and disrupted proper localization of kinetochore proteins, BubR1 and Bub 
(Yang et al., 2010). Astrin is associated with meiotic spindle microtubules with particular 
concentration at the spindle poles, and perturbation of its function greatly compromises 
normal spindle integrity and chromosome segregation (Yuan et al., 2009). The apoptosis 
inhibitor protein, survivin, mimics AMPK localization in mouse oocytes, and its 
depletion adversely affects chromosome alignment and alters normal polar body 
extrusion (Sun et al., 2009).  Another similarly localized kinase, Polo-like kinase-1 (Plk1), 
was implicated in spindle assembly in oocytes and later mitosis in the embryo after 
fertilization (Wianny et al., 1998; Tong et al., 2002).  In addition to regulating spindle 
organization, Plk1 also promotes M phase entry by participating in the MPF 
amplification loop (Karaiskou et al., 2004), and blocking its activity with antibody 
reduces the GVB rate (Tong et al., 2002).  Of particular relevance to the present study is 
the recent finding that pharmacological inhibition of Plk1 blocks AMPK activation and 
cytokinesis in HeLa cells (Vazquez-Martin et al., 2011).  Another kinase, protein kinase 
C delta (PKCδ), associates with γ-tubulin and pericentrin, and disruption of its function 
leads to spindle disorganization and misalignment of chromosomes (Ma and Koch, 2008). 
PKC has also been shown to be involved in the MI-to-MII transition (Viveiros et al., 
2001).  Finally, phospho-MEK1/2, the upstream kinase for MAPK activation, displays a 
prominent presence at the spindle poles in mouse oocytes, and blocking MAPK leads to 
meiotic spindle abnormalities and poor chromatin condensation (Sun et al., 2008).  It is 
plausible that AMPK interacts with one or more of these proteins to influence meiotic 
progression.  An alternate scenario is that the kinase docks at MTOCs without 
contributing to spindle assembly or function.   
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 In conclusion, both AMPK localization and activity in the mouse oocyte are 
dependent on intact microtubules.  Further, while perturbation of microtubule integrity 
blocks meiotic induction at the level of the oocyte, it has no effect on spontaneous 
maturation. This demonstrates that additional microtubule-sensitive modalities are 
required to overcome induction of maturation in meiotically arrested oocytes. Once 
isolated from follicles, oocytes undergo spontaneous maturation due to the loss of cGMP 
within oocytes. However, it is suggested that an additional unknown stimulus is 
generated for meiotic induction. This was supported by the fact that the frequency of the 
GVB in CEO after FSH stimulation was greater than the control arrested DO. If the effect 
of FSH on GVB is simply mediated by uncoupling of the somatic compartment, one 
should expect to see the same level of GVB as DO (Downs et al., 1988).  It is possible 
that this additional component is sensitive to microtubule perturbants. Altogether, our 
data lend further support to the idea that these are distinct processes.  
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CHAPTER III: SUPPRESSION OF CHEMICALLY INDUCED AND 
SPONTANEOUS MOUSE OOCYTE ACTIVATION BY AMP-
ACTIVATED PROTEIN KINASE 
Summary 
Oocyte activation is an important process triggered by sperm fertilization that 
initiates embryonic development.  However, parthenogenetic activation can occur either 
spontaneously or with chemical treatments.  The LT/Sv mouse strain is genetically 
predisposed to spontaneous activation.  LT/Sv oocytes have a cell cycle defect and are 
ovulated at the metaphase I stage instead of metaphase II.  A thorough understanding of 
the female meiosis defects in this strain remains elusive.  We have shown in chapter I that 
AMPK has an important role in stimulating meiotic resumption and promoting 
completion of meiosis I while suppressing premature parthenogenetic activation.  Here 
we show that early activation of AMPK during the oocyte maturation period blocked 
chemically induced activation in B6SJL oocytes and spontaneous activation in LT/SvEiJ 
oocytes.  This inhibitory effect was associated with high levels of MAPK 1/3 activity.  
Furthermore, stimulation of AMPK partially rescued the meiotic defects of LT/SvEiJ 
mouse oocytes in concert with correction of abnormal spindle pole localization of AMPK 
and prolonged spindle assembly checkpoint activity.  Altogether, these results confirm a 
role for AMPK in sustaining the MII arrest in mature oocytes and suggest that 
dysfunctional AMPK contributes to meiotic defects in LT/Sv oocytes. 
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Introduction 
Mammalian oocytes initiate meiosis during embryonic development and become 
arrested at the dictyate stage of prophase I around the time of birth.  Following a mid-
cycle gonadotropin stimulus, oocytes within preovulatory follicles resume meiosis, 
complete maturation and are ovulated at the metaphase II (MII) stage, where they remain 
arrested until fertilization.  Germinal vesicle breakdown is driven by M-phase promoting 
factor (MPF), a dimer containing catalytic CDK1 and regulatory cyclin B1 subunits; 
MPF activity drops during anaphase onset, then rises and stays elevated during MII arrest 
(Jones, 2004).  Binding of sperm triggers activation of the mature ovum, a series of 
events that includes calcium oscillations, completion of meiosis II, release of cortical 
granules, and initiation of embryonic development (Horner and Wolfner, 2008; Wakai et 
al., 2011).  Calcium signaling is a universal component of fertilization in the animal 
kingdom (Stricker, 1999); in vertebrates, calcium oscillations are an essential feature of 
egg activation and trigger release from MII arrest (Malcuit et al., 2006; Ducibella and 
Fissore, 2008). Cytostatic factor (CSF) is important for maintaining metaphase II arrest, 
which involves stabilization of MPF by the c-Mos/MAPK1/3 pathway and suppression of 
the anaphase promoting complex (APC) by early mitotic inhibitor 2 (Emi2) (Madgwick 
and Jones, 2007). Interrupting the c-Mos/MAPK1/3 pathway or mutation of mos leads to 
loss of MPF activity and premature egg activation (Colledge et al., 1994; Phillips et al., 
2002; Hashimoto et al., 1994); in addition, knockdown of Emi2 relieves the inhibition of 
APC that allows degradation of cyclin B and drives eggs into anaphase (Shoji et al., 2006; 
Madgwick et al., 2006), mimicking the effect of sperm-induced calcium oscillations 
(Nixon et al., 2002; Suzuki et al., 2010).  
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Oocyte aging, chemical treatment, and the intrinsic quality of the oocyte are 
factors that can lead to mouse egg activation in the absence of sperm (Kaufman, 1983).  It 
is well known that freshly ovulated oocytes are resistant to activation but become prone 
to activation with increased age and tenure in the oviducts (Marston and Chang, 1964; 
Kubiak, 1989; Xu et al., 1997).  Chemical treatments such as calcium ionophore 
(Nakagawa et al., 2001), phorbol ester (Cuthbertson and Cobbold, 1985; Sun et al., 1999), 
protein synthesis inhibitors (Siracusa et al., 1978; Fulka Jr et al., 1994), ethanol 
(Kaufman, 1982; Dyban and Khozhai, 1980; Cuthbertson, 1983) and heavy metals 
(O’Neill et al., 1991; Ma et al., 2005) are well characterized inducers of parthenogenesis 
in oocytes matured both in vivo and in vitro.  There are strain-dependent differences in 
oocyte susceptibility to spontaneous activation (Cheng et al., 2012), while altering 
metabolism or length of hormonal priming can induce parthenogenesis in strains that 
normally exhibit very low rates of activation (Downs, 1990; Downs et al., 2010).  
The LT/Sv strain is an inbred recombinant mouse line derived from C58 and 
BALB strains whose oocytes fail to complete meiosis, leading to arrest at metaphase I 
(Kaufman and Howlett, 1986; Maleszewski and Yanagimachi, 1995; Ciemerych and 
Kubiak, 1998), due to persistent MPF activity and a poor anaphase I trigger (Hirao and 
Eppig, 1997, 1999).  This MI arrest is associated with premature activation of oocytes 
within the ovary and a high incidence of ovarian teratomas (Stevens and Varnum, 1973; 
Eppig et al., 1977; Artzt et al., 1987).  The parthenotes advance to the egg cylinder stage 
but further development is disrupted, with formation of a disorganized mass of 
differentiated cell types (Stevens and Varnum, 1973).  A significant number of LT/Sv 
oocytes are ovulated at the metaphase I stage, and this arrest appears necessary, but not 
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sufficient, to induce parthenogenetic activation (Eppig et al., 1996; Everett et al., 2004).  
Apparently the protracted MI arrest brings about changes within the oocyte that 
predisposes it to activation.  The exact mutation(s) of the LT/Sv mouse remains unknown, 
but evidence suggests that the phenotype of LT/Sv oocytes is controlled by multiple 
alleles (Artzt et al., 1987; Eppig et al., 1996).  
In this series of experiments we further examined the relationship between AMPK 
and oocyte activation.  We report that AMPK activators suppress both chemically 
induced activation in oocytes from C57BL/6J×SJL F1 (B6SJL) mice and spontaneous 
activation in oocytes from LT/Sv mice during maturation in vitro, but are less effective in 
ovulated B6SJL oocytes.  This protection by AMPK was manifest during the oocyte 
maturation period and was associated with high levels of MAPK1/3 activity and the 
accelerated loss of the spindle assembly checkpoint protein, MAD2.  Stimulation of 
AMPK in LT/Sv oocytes rescued the “LT phenotype” by reducing the rate of 
parthenogenetic activation and promoting anaphase onset and PB formation.  These data 
support a multifunctional role of AMPK in mouse oocytes and suggest that AMPK 
dysfunction may contribute to meiotic defects in LT/Sv oocytes. 
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Materials and Methods 
Chemicals 
Unless otherwise noted, chemicals were supplied by Sigma-Aldrich Co. (St. Louis, 
MO). AICAR was from Toronto Research Chemicals, Inc. (North York, Ontario, Canada) 
and amphiregulin from R&D Systems (Minneapolis, MN).  Highly purified ovine FSH 
was obtained from the National Hormone and Peptide Program (NHPP) and Dr. A.F. 
Parlow.  Cy3-conjugated donkey anti-rabbit IgG was purchased from Jackson 
ImmmoResearch (West Grove, PA), Anti-phospho AMPK (PT172) antibody from Cell 
Signaling Technology (Beverly, MA), and rabbit anti-ERK1/2 and pERK1/2 (MAPK1/3) 
antibodies from Sigma Chemical Co.  Anti-MAD2 antibody was a kind gift from Dr. E.D. 
Salmon (Univ. North Carolina).  
Oocyte Isolation and Culture Condition 
All procedures were approved by the Marquette University Institutional Animal 
Care and Use Committee.  Immature, 20-23-day-old C57BL/6J✕ SJL/J F1 (B6SJL) and 
LT/SvEiJ female mice were used for all experiments.  Mice were primed with 5 IU 
pregnant mare serum gonadotropin (PMSG) and oocytes were isolated 2 d later.  For 
superovulation, 5 IU human gonadotropin (hCG) was administered IP 44-48 h post-
PSMG and oocytes were isolated at varying times thereafter.  Mice were killed by 
cervical dislocation and either ovaries or oviducts were removed and placed in a petri 
dish containing culture medium.  Cumulus cell-enclosed oocytes (CEO) were isolated by 
puncturing the follicles with sterile needles.  Denuded oocytes (DO) were obtained by 
stripping cumulus cells with a mouth operated small-bore pipette.  Oviducts were 
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punctured with sterile needles to release the expanded cumulus masses, which were then 
treated briefly with hyaluronidase to remove cumulus cells.   
 Both CEOs and DOs were washed twice and transferred to plastic culture tubes 
containing 1ml of the appropriate test medium.  The culture medium used was Eagle 
minimum essential medium (MEM) supplemented with penicillin, streptomycin sulfate, 
0.23 mM sodium pyruvate and 3 mg/ml lyophilized crystallized bovine serum albumin 
(MP Biomedicals, Solon, OH).  Calcium was omitted from the medium when activation 
was stimulated with strontium or calcium ionophore A23187.  
Chemical Activation  
Figure 1 depicts the three activation schemes used in this study.  Spontaneous 
maturation system was used in this research. CEOs or DOs were cultured 17 h in control 
MEM prior to treatment with chemical activators.  Cumulus cells were removed from 
CEOs at the end of this initial culture period so that only DOs received the activation 
stimulus.  The three activation regimens are as follows: 
 1. Strontium.  2.5 h in calcium-free MEM containing 1 mM strontium, wash and 
3.5 h culture in control MEM. 
 2. A23187/puromycin.  5 min in control MEM containing 5 µM calcium 
ionophore A23187, wash and 6 h culture in control MEM containing 10µg/ml puromycin. 
 3. Ethanol.  7 min in control MEM containing 7% EtOH, wash and 6 h culture in 
control MEM. 
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CEOs or DOs were exposed to AMPK activators (0.2 mM AICAR, 2mM AMP, 
or 2 µM RSVA405) during meiotic maturation (pre-maturation) or during/after the 
activation procedure (post-maturation).  CEOs were hormonally stimulated with 0.1 
µg/ml FSH or 50 µg/ml amphiregulin during meiotic maturation.  Oocytes were 
considered to be activated if they contained a pronucleus, two polar bodies with or 
without pronucleus, or had undergone cleavage. 
Immunofluorescent Staining 
 Cumulus cell-free oocytes were fixed with 4% formaldehyde in PBS at 4°C 
overnight.  They were then permeabilized 30 min with 0.1% triton-100 in blocking 
solution, which contained 10% donkey serum and 0.5 mg/ml saponin in PBS, followed 
by 1h in blocking solution.  Oocytes were incubated with primary antibody (1:100) 
overnight at 4°C (either rabbit anti-pPRKAThr172 or rabbit anti-MAD2 antibody), and 
washed 4 times at room temperature in blocking buffer.  This was followed by 1 h 
incubation with FITC-conjugated mouse anti-tubulin antibody (1:100) and Cy3-
conjugated donkey anti-rabbit IgG antibody (1:100) at room temperature. Some oocytes 
were stained for actin using Alexa 568 Fluor phalloidin (Life Technologies, Grand Island, 
NY) during the secondary antibody culture period.  Oocytes were washed four times, 
placed on slides and mounted with medium containing DAPI (Vector Laboratories, 
Burlingame, CA).  
Confocal Microscopy 
 Oocytes were observed on a laser scanning confocal microscope (Carl Zeiss Co., 
Thornwood, NY) with a 63X objective.  During scanning, all settings were kept constant: 
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i.e., laser power, detector gain, amplifier offset, amplifier gain, and pinhole size.  
Digitally recorded images were exported by LSM Examiner software (Carl Zeiss Co.).  
Western Blot Analysis 
 Oocyte samples were washed with PBS/PVP, then twice with protease inhibitor 
cocktail (Roche, Indianapolis, IN).  Samples were lysed by Laemmli’s buffer with 20% 
beta-mercaptoethanol at 95°C for 5 minutes.  Electrophoresis was carried out using 
NuPAGE 4-12% Bis-Tris Gels (InVitrogen, Carlsbad, CA), and proteins were transferred 
to nitrocellulose membranes.  Membranes were blocked with 5% non-fat milk, followed 
by incubation with rabbit anti-pERK1/2 (pMAPK1/3) antibody (1:1000) at 4°C overnight.  
Blots were rinsed twice with TBS (pH 7.4) and once with TBS-Tween-20 (0.05%), 
followed by incubation with HRP-conjugated goat anti-rabbit IgG antibody (1:5000 in 5% 
non-fat milk; Thermo Scientific Pierce, Rockford, IL) at room temperature for 1 h. After 
washing, protein signals were detected by super signal west pico chemiluminescent 
substrate (Thermo Scientific Pierce). Blots were stripped with restore western blot 
stripping buffer (Thermo Scientific Pierce) at room temperature for 15 min and reprobed 
with rabbit anti-MAPK1/3 antibody (1:1000).  pMAPK1/3:MAPK1/3 ratios were 
quantified with ImageJ software based on protein band density. 
Statistical Analysis 
 All experiments were repeated at least three times and data presented as mean ± 
SEM.  Percentages of activation, polar body, or MAD2 staining underwent arcsin 
transformation and data were analyzed statistically by ANOVA followed by Duncan’s 
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multiple range test.  Students T-test was used to compare paired treatments in some 
experiments. A P-value <0.05 was considered significant.  
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Results 
Effects of AMPK activators on chemically induced activation in B6SJL oocytes 
 We have previously shown that the AMPK activator, AICAR, prevents premature 
activation in spontaneously activating oocytes from B6SJL mice when present during 
meiotic maturation (Downs et al., 2010).  To test if AMPK stimulation would also block 
activation induced by chemical treatments, we adopted three different protocols 
depending on the agent(s) used to stimulate activation: strontium, A23187/puromycin or 
ethanol.  For all three treatments, CEOs or DOs were cultured 17 h in control MEM to 
allow for meiotic maturation.  Remaining cumulus cells were then removed from CEOs, 
and these cumulus cell-free oocytes as well as the mature DOs were exposed to chemical 
activating conditions (see Figure 3.1). 
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Figure 3. 1 Schematic diagram of activation protocols 
For all treatment regimens, CEOs or DOs were first cultured 17 h in control medium to permit 
completion of spontaneous maturation.  When appropriate, cumulus cells were then removed from CEOs, 
and DOs were exposed to chemical activating conditions.  (A).  Oocytes were treated with strontium in 
calcium-free MEM for 2.5 h, washed and then transferred to control MEM for 3.5 h.  (B).  Oocytes were 
exposed to 7% ethanol for 7 min, washed and then transferred to control MEM for 6 h.  (C).  Oocytes were 
treated with A23187 for 5 min, washed and then transferred to puromycin for 6 h.  
 Strontium-induced activation.  The first series of experiments utilized the 
activating agent strontium, and cultures were carried out in calcium-free medium, since 
the absence of calcium has previously been demonstrated to augment activation by this 
agent (Whittingham and Siracusa, 1978).  After removing cumulus cells from matured 
CEO, oocytes were exposed to 1 mM strontium in calcium-free MEM for 2.5 h, followed 
by 3.5 h incubation in the calcium-containing medium.  In control oocytes not exposed to 
strontium, only 4% were activated compared to 70% activation in strontium-treated 
oocytes (Figure. 3.2A). Supplementation of AICAR during the initial maturation period 
significantly reduced this number to 15%. Interestingly, later addition of AICAR only 
showed a modest reduction of activation (57%, Figure 3.2A).  In the next experiment, we 
tested the direct effects of AICAR on strontium activation of matured DOs, utilizing the 
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same protocol that was used with CEOs.  In the absence of cumulus cells, no activation 
was observed in oocytes that were only exposed to calcium-free medium, but strontium 
treatment only induced 34.8% of DOs to activate.  AICAR blocked strontium-induced 
activation, and the effect of exposure during meiotic maturation was comparable to that 
when exposure followed maturation (Figure. 3.2A). 
When the experiment was repeated with native AMP, similar results were 
obtained.  Exposure to AMP during first culture period significantly reduced the 
activation rate in CEOs from 71% to 23% (compared to 4% in controls), whereas 
exposure to AMP post-activation did not prevent the activation (Figure. 3.2B).  When the 
experiment was repeated in DOs, a similar suppression of activation was obtained if 
AMP treatment occurred during the maturation period; however, surprisingly, treatment 
post-maturation with AMP increased the level of activation (Figure. 3.2B). 
We repeated the experiment using a newly described resveratrol analog, 
RSVA405(Vingtdeux et al., 2011), which activates AMPK like AICAR, and was proven 
to be effective in promoting GVB and PB formation in the mouse oocytes (data not 
shown). Consistent with the AICAR and AMP results, RSVA405 suppressed strontium-
induced activation in both CEOs and DOs only when present during the initial maturation 
period (Figure 3.2C).  
 FSH and the EGF-like peptide, amphiregulin (AR), are both potent stimulators of 
meiotic maturation of mouse CEOs in vitro, with downstream activation of oocyte 
AMPK preceding GVB (Chen and Downs, 2008).  We predicted that, because of their 
AMPK-stimulating capability, treatment of CEOs with either of these peptides would 
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block strontium-induced activation.  For this experiment, FSH and AR were present only 
during the initial maturation period.  These results are shown in Figure. 3.2D.  As 
expected, FSH and AR significantly reduced the activation rate from 77% to 38% and 
33%, respectively.  
Since the data suggest that AMPK activation during the maturation period is 
important to prevent later strontium-induced activation, an experiment was carried out to 
determine the window of requirement for AMPK activation to achieve protective effect 
by delaying AICAR treatment by 0,6 or 8 h (Figure 3.2E). There was no loss of 
protection when AICAR treatment was delayed by 6 h; however, AICAR started losing 
its protective effect when the exposure was delayed by 8 h. This suggests that maximum 
protection requires exposure within 6h of the initiation of culture, a time point 
corresponding to the early spindle formation. 
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Figure 3. 2 Effect of AMPK stimulation and hormones on strontium-induced activation 
Treatment with AICAR (A), AMP (B) or RSVA405 (C) during oocyte maturation (pre-maturation) 
prevented strontium-induced activation in both CEO and DO, but supplementation after the 17-h 
maturation period (post-maturation) was relatively ineffective.  (D). Amphiregulin (AR) or FSH suppressed 
strontium-induced activation in CEO when present during the initial maturation period.  (E). Effect of 
delaying AICAR treatment on strontium-induced activation. The inhibitory effect of AICAR on activation 
in CEO was decreased when AICAR treatment was initiated 8 h, but not 6 h after the start of culture.  All 
data are presented as mean percent activated ± SEM.  Groups with no common letter are significantly 
different (CEO: a-d; DO, w-z).  
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Since the cMos-MAPK1/3 pathway is important for maintaining MII arrest 
(Colledge et al., 1994; Hashimoto et al., 1994; Phillips et al., 2002), we tested the effect 
of AMPK activation in CEO on MAPK1/3 activity following strontium activation.  
Oocytes were collected for western blot at 17 h (after maturation), 19.5 h (post-strontium 
treatment) and 23 h (after final recovery). As shown in Figure 3.3, control oocytes that 
were treated with calcium-free medium alone maintained a high level of MAPK1/3 
activity at all three time points.  In contrast, oocytes that were treated with strontium 
exhibited decreased MAPK1/3 activity after the second and third culture periods.  
Consistent with their preventive effect on activation, both AMP- and AICAR-treated 
oocytes maintained high MAPK1/3 activity at all time points tested.  
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Figure 3. 3 Maintenance of MAPK1/3 activity in oocyte treated with AICAR( AIC) or AMP during 
maturation 
(A). Representative western blot analysis of p-MAPK1/3 in oocytes treated as described in Figure. 
1A.  Denuded oocyte extracts were subjected to western blot analysis at the end of each of the three 
treatment phases.   +/- in the 2nd culture indicates the presence or absence of strontium.  Con, control.  (B). 
Quantitative analysis of pMAPK1/3 signals from western blot, presented as a ratio of the band intensity of 
pMAPK1/3 to that of non-phosphorylated MAPK1/3.  Mean ± SEM of three blots.   Treatments with either 
AICAR or AMP maintained high pMAPK1/3 levels that were comparable to the control group.  Data are 
presented as mean ratio ± SEM.  
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 A23187/Puromycin-Induced Activation.  CEOs were used to test the ability of 
AICAR to reverse the activation resulting from sequential treatment of calcium 
ionophore A23187 followed by the protein synthesis inhibitor, puromycin.  Mature 
oocytes were cultured 5 min in 5 µM calcium ionophore A23187 followed by 6 h in 
10µg/ml puromycin (Figure. 3.1).  In the control group treated with ionophore alone, only 
12% of the oocytes underwent activation (Figure. 3.4A).  When ionophore-treated 
oocytes were subsequently exposed to puromycin, the activation rate was increased to 
66%.  If oocytes were exposed to AICAR during puromycin exposure, there was no 
significant reduction in activation (43%); however, a significant decrease occurred when 
AICAR was present during the initial maturation period (31% activation; Figure. 3.4A). 
 Ethanol-Induced Activation.  CEOs were used to test the effect of AICAR on 
ethanol-induced activation.  When oocytes were exposed for 7 min to 7% ethanol 
followed by 6 h culture in control medium (Figure. 1), 78% of the oocytes underwent 
activation compared to 1% of controls (Figure. 3.4B).  If CEOs were treated with AICAR 
during the initial maturation period, ethanol-induced activation was reduced by 54%, 
while restricting AICAR treatment to the last 6 h had no effect. 
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Figure 3. 4 Treatment with AICAR on A23187/puromycin- and ethanol-induced activation 
Treatment with AICAR during, but not following, oocyte maturation blocked A23187/puromycin-
induced (A) and ethanol-induced (B) activation in CEO.  Data are presented as mean percent activated ± 
SEM.  Groups with no common letter are significantly different. 
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Effect of AMPK activation on in vivo aged B6SJL oocytes 
 It has been well documented that increased aging of ovulated oocytes within the 
oviduct increases their susceptibility to spontaneous activation (Marston and Chang, 
1964; Kubiak, 1989; Xu et al., 1997).  This was confirmed when eggs were retrieved 
from the oviducts of superovulated B6SJL mice 16, 20 and 24 h post-hCG and cultured 6 
h in control medium.  The percentage of activation increased in direct relationship to the 
time post-hCG the eggs were retrieved (2, 12 and 32% activation, respectively); there 
was a modest trend for suppression of activation at all time points when AICAR was 
present during 6 h culture (0, 8 and 22% activation, respectively; Figure. 3.5). 
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Figure 3. 5 Effect of AMPK on activation of in vivo matured oocytes 
Oocytes were retrieved from oviducts 16, 20 and 24 h post-hCG and cultured 6 h with or without 
AICAR.  Although there was a trend toward less activation in AICAR-treated oocytes, differences were not 
significant.  Data are presented as mean percent activated ± SEM. 
Effects of AMPK activators on oocyte activation in the LT/SvEiJ strain 
   Oocytes from the LT/Sv mouse strain exhibit a high rate of spontaneous 
activation (Eppig et al., 1977).  It was therefore important to determine if AMPK 
activators would also suppress this type of oocyte activation.  We initially compared 
spontaneous activation rates in oocytes from B6SJL and LT/SvEiJ (hereafter designated 
LT) mice following 30 h culture in the presence or absence of AICAR.  In the absence of 
AICAR, activation rates were 2 and 21%, respectively, while AICAR reduced these rates 
to 0 and 4% (Figure. 3.6A). When LT CEOs were treated with RSVA405, a similar 
reduction in activation was observed (Figure. 3.6B). 
To determine the critical window for AMPK activity required to convey this 
suppressive effect on LT oocyte activation, oocytes were first cultured in either MEM or 
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medium containing AICAR for 17 h, then were transferred to MEM or AICAR 
containing medium for another 13 h before activation was assessed. As shown in Figure 
3.6C, LT oocytes showed high levels of activation when they were cultured in 
control/control and control/AICAR medium. However, the activation rates were 
significantly reduced when oocytes were cultured in AICAR/AICAR and AICAR/MEM. 
These results are consistent with earlier experiments in B6SJL oocytes showing a 
protective effect of AICAR during the initial period of oocyte maturation.   
 In addition to high rates of spontaneous activation, LT oocytes also fail to 
progress past metaphase I both in vivo and during spontaneous maturation in vitro 
(Kaufman and Howlett, 1986; Hirao and Eppig, 1997; O’Neill and Kaufman, 1987).  
Thus, we tested whether AMPK stimulation could overcome this meiotic defect.  CEO 
from B6SJL and LT mice were cultured in either control or AICAR-containing medium 
for 17 h and assessed for polar body formation.  In B6SJL oocytes, 53% formed polar 
bodies in control medium, while AICAR increased this number to 78% (Figure.3. 6D).  
No polar bodies were observed in LT oocytes cultured in control medium, but 22% of 
AICAR-treated oocytes extruded a polar body. 
 When LT oocytes were stained for active AMPK after 17 h culture in control 
medium, we observed a high incidence of abnormal localization.  Instead of staining at 
both spindle poles, which is the typical staining pattern in B6SJL oocytes, in most LT 
oocytes the localization was either shifted away from the poles or was absent at one or 
both of the poles (data not presented).  Since LT oocytes are arrested at MI for a 
prolonged period of time, to eliminate the possibility that this phenotype was due to an 
aging effect, we stained oocytes for active AMPK after 8 h in both B6SJL and LT strains, 
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when MI has been freshly established, and compared MI localization patterns between 
the two strains.  Seventy-five percent of B6SJL MI-stage oocytes cultured in control 
medium exhibited active AMPK at both spindle poles (Figs 3.6E, 3.7A).  However, only 
28% of LT MI-stage oocytes had similar bipolar staining (Figs. 3.6E, 3.7B,C).  Treatment 
with AICAR had no effect in B6SJL oocytes, but doubled the percentage of LT oocytes 
with normal AMPK staining (57%).   
  A comparison of meiotic status in these same oocytes showed that 97% of B6SJL 
oocytes cultured 8 h in control medium reached prometaphase or metaphase I, with 3% in 
anaphase (Figure. 3.6F).  Similarly, 100% of LT oocytes were at metaphase I or 
prometaphase.   The addition of AICAR accelerated meiotic progression, such that 71% 
of B6SJL oocytes were at anaphase or beyond after 8 h of culture.  In addition, 33% of 
LT oocytes were at anaphase after exposure to AICAR, which, along with the polar body 
data above, demonstrates AICAR-induced rescue from metaphase arrest in a significant 
percentage of the oocytes.   
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Figure 3. 6 Effects of AMPK stimulation on LT/SvEiJ oocytes 
 (A). AICAR blocked spontaneous activation in LT oocytes during 30 h cultures.  (B). RSVA405 
had a similar inhibitory action on LT activation.  Asterisks in A and B denote a significant difference from 
controls (Con).  (C). AICAR blocked activation in LT oocytes when present during, but not after, oocyte 
maturation.  LT/Sv oocytes were first cultured in control MEM (Con) or AICAR for 17 h, and then 
transferred to control or AICAR-supplemented medium for another 13 h before activation was assessed.  A 
different letter denotes a significant difference.  (D). AICAR stimulated PB formation in both B6SJL and 
LT oocytes during 17 h cultures.  An asterisk denotes a significant difference from controls (Con).  Data in 
A-D are presented as percent activation or PB ± SEM.  (E) and (F).  pPRKA (PT172) localization (E) and 
stage of meiosis (F) in MI stage oocytes after 8 h of culture.  AICAR increased the percentage of normal 
PT172 spindle pole localization in LT oocytes and increased the percentage of anaphase I (Ana) in oocytes 
from both the B6SJL and LT strains.  Pro, prometaphase.   
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Interestingly, in addition to abnormal active AMPK localization, some AICAR- 
treated LT oocytes underwent karyokinesis without cytokinesis after 17h of culture. The 
chromosomes were segregated, and MII spindle was established. Actin filament staining 
by phalloidin did not detect PB, although the oocytes showed the presence of actin cap, 
which is the site close to future PB extrusion and with excessive polymerization of actin 
filaments (Figure 3.7D, E). These data suggest that despite the fact that AMPK 
stimulation can promote anaphase onset and PB formation, the LT oocytes still manifest 
the defect in cell cycle progression.  
AICAR Promotes the Loss of Chromosomal MAD2 Staining         
 It has been previously reported that prolonged spindle assembly checkpoint 
(SAC) activity contributes to MI arrest in LT oocytes (Hupalowska et al., 2008).  To test 
the hypothesis that stimulation of AMPK promotes anaphase onset by overcoming SAC 
activity, oocytes were stained for MAD2, one of the major components of SAC (Waters 
et al., 1998).  We first determined the kinetics of centromeric MAD2 loss in B6SJL CEO 
(Figure. 3.7F).  Although MAD2 staining intensity was reduced in control oocytes by 6 h, 
95% of them still remained positive.  Between 6 and 8h the number of MAD2-positive 
oocytes decreased by 50%. AICAR treatment accelerated the loss of MAD2, with only 
61% and 23% positively staining oocytes at 6 and 8h, respectively.  In LT CEO, 98% 
stained positive for MAD2 after 8 h of culture, whereas in the AICAR-treated group, it 
was reduced to 41% (Figure 3.7G, H, I). 
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Figure 3. 7 Immunofluoresecent staining in LT oocytes 
(A-C). Immunofluorescent staining of active AMPK in LT oocytes.  (A). Normal spindle pole 
localization of active AMPK.  (B). Shifted spindle pole localization.  (C). Missing spindle pole localization.  
Green, a-tubulin; Red, pPRKAThr172; Blue, DAPI. (D) and (E). 3D projection of LT oocytes stained with 
actin (red) and tubulin (green). Representative staining of oocytes with (D) and without PB (E).  (F-I). 
AICAR treatment accelerated loss of MAD2 in kinetochores. (F). Kinetics of centromeric MAD2 loss in 
B6SJL oocytes in the presence or absence of AICAR.  (G). AICAR treatment eliminated prolonged MAD2 
kinetochore localization in LT oocytes.  The data in (F) and (G) are presented as percent positive MAD2 
stain± SEM; the asterisk denotes a significant difference from –AICAR controls.  (H) and  (I). MAD2 stain 
in LT oocytes that were cultured 8 h in control (H) or AICAR-supplemented (I) medium.  Red, MAD2; 
Blue, DAPI.  
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Discussion 
In this study, we demonstrate the suppressive effects of AMPK activators on 
parthenogenetic activation in mouse oocytes.  Stimulation with the AMPK activators 
AICAR, AMP or RSVA405 during oocyte maturation prevented both chemically induced 
activation in B6SJL mice and spontaneous activation in LT mice, while exposure of 
oocytes to these agents after maturation had little effect on either type of activation.  
Stimulating AMPK in ovulated, in vivo-matured B6SJL eggs was relatively ineffective in 
preventing activation, likely due to the fact that the eggs were already mature at the time 
of treatment.  Additional effects of AMPK activation on LT oocytes included changes in 
active AMPK localization, release from metaphase arrest and a reduction in spindle 
checkpoint activity.  
Treatment of mouse oocytes with strontium produces repetitive calcium 
oscillations that mimic the effect of sperm binding, making it one of the most effective 
chemical activating agents (Whittingham and Siracusa, 1978; Bos-Mikich et al., 1995; 
Alberio et al., 2001).  Nevertheless, exposure to AICAR, AMP or RSVA405 was 
sufficient to block strontium-induced activation in both CEO and DO, indicating a direct 
action on the oocyte.  Twice as many oocytes were activated in CEO compared to DO, 
confirming that the presence of cumulus cells during the maturation period promotes 
activation (Eppig, 1982; Eppig et al., 2000).  The protection by AMP and AICAR was 
associated with maintenance of MAPK1/3 phosphorylation, which suggests AMPK may 
prevent activation by blocking dephosphorylation of MAPK1/3 and keeping MPF activity 
high (Madgwick and Jones, 2007). At this point, we are not sure how this interaction 
between AMPK and MAPK happens.  Inappropriate activation of the cMos/MAPK1/3 
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pathway in Xenopus oocytes can induce a metaphase cell cycle arrest (MacNicol et al., 
1995; Daar et al., 1991), while treating oocytes with inhibitors of MAP2K1 (MEK1), the 
immediate upstream MAPK1/3 kinase, alleviates metaphase arrest and stimulates 
activation (Hashimoto et al., 1994; Tong et al., 2003). Because treatment with AMPK 
activator and strontium were temporally separated, it is possible that this action of AMPK 
may reflect an indirect upstream effect, preventing an activation stimulus that acts on the 
MAPK1/3 pathway.  Strontium-induced oocyte activation involves the interaction of 
phospholipase and InsP3 receptor (Zhang et al., 2005) and it is possible that AMPK 
activation also interferes with these processes (see also Ross et al., 2008).  
Calcium ionophore A23187 only produces a single calcium spike. A23187 and 
protein synthesis inhibitors alone each modestly stimulate oocyte activation, but when 
oocytes are treated sequentially with these two agents, synergistic activation is observed 
(Bos-Mikich et al., 1995; Nakasaka et al., 2000; Nakagawa et al., 2001; Lu et al., 2006).  
Brief exposure to ethanol is also an effective trigger for parthenogenetic activation, 
likewise acting through simple calcium transients (Alberio et al., 2001; Cuthbertson et al., 
1981; Winston et al., 1995). Nevertheless, both of these treatments produced activation 
frequencies comparable to those achieved with strontium.  More importantly, AMPK 
activators suppressed both A23187/puromycin- and ethanol-induced activation with a 
potency resembling that for strontium-treated oocytes.  These results are important 
because they demonstrate a consistent activation-suppressing response to AMPK 
stimulators regardless of the type of chemical activating stimulus.   
Hormonal stimulation was protective for oocytes against chemically induced 
activation. This protective effect might be mediated by AMPK, since we have previously 
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demonstrated that these ligands activate the AMPK pathway within the oocytes (Chen 
and Downs, 2008).  However, it should be noted that the strontium- induced activation 
rate in FSH-treated CEOs was reduced to the level of DO. It is also possible that 
hormone-induced uncoupling of the oocytes from cumulus cells decreases the pro-
activation effect of cumulus cells (Eppig, 1982), thereby rendering it a physiologically 
denuded oocyte that is less sensitive to strontium treatment.  
AMPK activation during oocyte maturation was essential for optimal protection 
from chemically induced activation; later treatment with AMPK activators during either 
the activation or recovery periods was largely ineffective. We observed this relationship 
consistently for CEOs. However, for DOs, while the exposure of AMPK stimulators 
during the maturation period was always inhibitory to activation, the results for recovery 
period treatments varied among the groups: RSVA405 had no effect, AICAR was 
inhibitory, and, curiously, AMP was stimulatory. This may be due to the fact that the 
potency of the activators are different between CEOs and DOs, or in the case of AMP, 
there may be an additional effect on the oocyte. This early requirement for AMPK 
activation for preventing activation is consistent with our in vivo oocyte maturation data; 
AICAR was less effective in preventing spontaneous activation when oocytes were 
already matured at the time of the treatment. Further, the AICAR timing experiments 
showed that treatment with kinase activator could be delayed up to 6 h after the initiation 
of culture and still achieve full protection against activation, a time point that roughly 
corresponds to metaphase spindle formation.  After 6 h, physiological changes begin to 
manifest in the oocyte that make it more susceptible to activating conditions that AMPK 
activators cannot overcome.  Interestingly, this temporal sensitivity is different than that 
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for AMPK promotion of PB formation, which requires earlier exposure to AMPK 
activators, around the time of GVB (less than 4h) (Downs et al., 2010).  Thus, AMPK not 
only induces initiation of meiotic resumption and promotes PB, but also suppresses 
oocyte activation, though the data suggest its action is required at different time points 
during the maturation period to achieve these effects. 
Most LT oocytes have a deficit in cell cycle progression, arresting and ovulating 
as metaphase I stage as opposed to metaphase II (Kaufman and Howlett, 1986; 
Maleszewski and Yanagimachi, 1995; Ciemerych and Kubiak, 1998), and this metaphase 
I arrest is associated with the spontaneous activation phenotype (Eppig et al., 1996), 
though the exact link is obscure. Exposure of AMPK activators during the initial 
maturation period not only prevented chemically induced maturation in B6SJL, but also 
inhibited the spontaneous activation of LT oocytes. Based on the Western blot analysis of 
MAPK1/3 activity in B6SJL, it is reasonable to propose that AMPK also acts as the same 
way in preventing LT oocyte activation. Hirao and Eppig suggested a role for CSF in the 
prolonged metaphase I arrest in LT oocytes based on the fact that high levels of 
MAPK1/3 activity is maintained in the LT oocytes (Hirao and Eppig, 1997, 1999; 
Maleszewski and Yanagimachi, 1995); however, in wild type oocytes high CSF activity 
did not initiate the metaphase I arrest, but only delayed the metaphase-to-anaphase 
transition, which suggested that CSF is not the primary cause of metaphase I arrest in this 
strain, though it may help maintain it.  
If the metaphase I arrest in LT oocytes is, indeed, linked to parthenogenesis, then 
it is not surprising that AMPK also stimulated meiotic progression past this arrest point.  
Recently, it was reported that prolonged spindle assembly checkpoint (SAC) activity is 
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involved in the metaphase I arrest of the LT oocytes (Hupalowska et al., 2008; 
Maciejewska et al., 2009). To further address possible downstream mediators of AMPK, 
we investigated whether AMPK altered spindle assembly checkpoint dynamics.  SAC is a 
surveillance mechanism that monitors the integrity of the mitotic spindle and proper 
attachment of chromosomes to spindle microtubules and controls activation of the 
anaphase-promoting complex (APC) (Chen et al., 1996; Li and Benezra, 1996; Waters et 
al., 1999). The same surveillance mechanism also exists in meiotic cells. MAD2 is one of 
the components of the SAC complex in mouse and rat oocytes that localizes to 
unattached kinetochores, sequestering the main component of APC, Cdc20, thereby 
inhibiting APC activity and keeping MPF activity high (Zhang et al., 2004; Wassmann et 
al., 2003a).  MAD2 is required in mouse oocytes for maintaining MI and preventing 
premature anaphase (Wassmann et al., 2003b; Homer et al., 2005; Wang et al., 2009).  
Interestingly, as LT oocytes (Hupalowska et al., 2008) or mice (Hoffmann et al., 2012) 
age, the MI arrest attenuates, coincident with declining SAC activity.  We have shown 
herein that AICAR activation stimulated the loss of chromatin MAD2 staining, in concert 
with promoting anaphase onset.  It is therefore likely that AMPK activator-induced loss 
of MAD2 kinetochore binding contributes to both its acceleration of meiosis in B6SJL 
oocytes and rescue of LT oocytes from MI arrest and activation.  The exact mechanism 
on how AMPK regulates MAD2 dynamics remains to be determined.  
Ciemerych and Kubiak proposed the major cause for LT phenotype is due to a 
lack of an appropriate anaphase I trigger (Ciemerych and Kubiak, 1998). In our study, 
activating AMPK provided such a trigger by altering the kinetochore binding dynamics 
of MAD2, presumably by affecting SAC activity. Our data suggest that completion of 
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maturation driven by AMPK stimulation has a protective role on premature activation. 
This is also consistent with the previous compound C data from Chapter I, which blocked 
oocyte maturation at metaphase I and induced oocyte activation. In fact, upon close 
observation, treating LT oocytes with AICAR reduced activation by 18% (Figure. 3.6A), 
which was offset by the number of oocytes that progress to MII (21%; Figure. 3.6D).  
Hence, it is tempting to speculate that the LT oocytes that would have activated in the 
absence of AICAR are those same oocytes stimulated to reach MII in its presence and 
that the nearly complete suppression of activation is due to meiotic escape from MI.  
Why the remaining MI-arrested oocytes do not activate is not clear, but it appears that 
only about one-fifth of the LT oocytes are prone to activation in our culture conditions. 
Also, it would be interesting to know if AMPK stimulation affects the ploidy of the 
resulting secondary oocytes, since AICAR treatment accelerated the MAD2 loss from the 
kinetochore and the AICAR-treated oocytes enter anaphase earlier than the controls. 
Curiously, the percentage of AMPK-treated LT oocytes that entered anaphase 
(33%) was higher than the number extruding a PB (21%).  This suggested that 
karyokinesis occurred in the absence of cytokinesis in a small population of these oocytes.  
Indeed, when we stained actin filaments with phalloidin, 4% of AICAR-treated oocytes 
after 17 h of culture contained separated homologous chromosomes with a MII spindle, 
yet no sign of a PB or contractile ring. The normal polymerization of the actin cap close 
to the meiotic spindle suggests that the initial steps of cytokinesis happened successfully 
in AICAR-treated LT oocytes, while it is most likely that the downstream formation of 
contractile ring was affected.  This is supported by the fact that myosin regulatory light 
chain (MRLC), an important protein involved in the regulation of contractile ring 
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formation, has recently been shown to be a downstream target of AMPK (Lee et al., 
2007; Thaiparambil et al., 2012). If abnormal functioning of AMPK is a major 
contributing factor of the LT phenotype, it would be interesting to see if MRLC 
localization and function is affected in LT oocytes and how it is related to the partial 
rescue of meiosis I arrest by AICAR. It is also possible that a small number of oocytes 
had segregated homologous chromosomes that reaggregated after anaphase onset 
(Dumont et al., 2007; Pfender et al., 2011). To distinguish these possibilities, a further 
observation under time-lapse microscopy is needed. 
When LT oocytes were stained for active AMPK after 8 h of culture, abnormal 
localization was frequently observed. This was not due to an aging effect following 
prolonged MI arrest, because it was observed in oocytes with newly formed meiotic 
spindles.  Although some control B6SJL oocytes also showed abnormal spindle pole 
localization, it was much less frequent.  Importantly, supplementation of AICAR 
significantly lowered the incidence of AMPK mislocalization in LT oocytes, which 
suggests that LT oocytes may have insufficient AMPK function.  It has been reported that 
metaphase I-arrested LT oocytes have more organized centrosomal material on one 
spindle pole than the other (Albertini and Eppig, 1995).  This could help explain the 
missing or shifted spindle pole localization of active AMPK in these oocytes, since active 
AMPK colocalizes with microtubule organizing centers (Chapter II).  
Our results support the possibility that defective control of AMPK activity 
contributes to the LT phenotype.  Genes for the two AMPK catalytic subunits, Prkaa1 
and Prkaa2, are located on mouse chromosomes 15 and 4, respectively.  However, a 
whole genome scan determined that regions in chromosome 1 and 9 were likely 
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responsible for LT oocyte defects (Everett et al., 2004).  It may be that dysregulation of 
AMPK is a downstream consequence of abnormal genetic control in these regions.  
Regardless, it is apparent that AMPK has a profound influence on meiotic progression 
and regulation of parthenogenetic activation in both B6SJL and LT oocytes.  Up to this 
point, our experiments have depended largely upon pharmacological manipulation of 
AMPK, and genetic ablation experiments are needed for confirmation.  Both isoforms of 
the catalytic subunit have been knocked out in mice and each is viable and able to 
reproduce; however, the double knockout is an embryonic lethal (Viollet et al., 2009).  It 
will be important to eliminate both isoforms in the oocyte to determine if AMPK is a 
requisite player or merely serves to fine tune these physiological processes.  
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SUMMARY AND CONCLUSION 
 The data presented herein suggest an involvement of AMPK in the entire 
sequence of events, involving mouse oocyte maturation and subsequent activation. It has 
been demonstrated that the activation of AMPK mediates hormone-induced meiotic 
resumption in mouse oocytes, and most significantly, the activation precedes GVB. As a 
continuation of these study, I investigated the role of AMPK in the completion of 
maturation and subsequent oocyte activation process. Surprisingly, AMPK not only had a 
role in the meiotic resumption, it also promoted the first polar body formation and 
suppressed premature activation. The subsequent study revealed the potential sites of 
action for AMPK in meiosis: the positive effect on PB formation is associated with the 
accelerated anaphase onset by regulating the dynamics of MAD2 protein localization at 
the kinetochores, whereas the inhibitory effect on oocyte activation was linked to the high 
levels of MAPK activity, which is critical for maintaining metaphase II arrest.  
All evidence suggests a multifunctional role of AMPK in the mouse oocytes 
(Figure 4.1). Interestingly, there is a temporal disconnect between the requirement of 
AMPK activity and its effects on PB extrusion and oocyte activation.  In both cases, the 
activity is required early during the maturation period. Consistent with the sequential 
events of PB formation and oocyte activation, AMPK activity is required within 4h after 
initiation of maturation for optimal promotion of PB and the AICAR treatment can be 
delayed up to 6h without losing the maximum protection against oocyte activation. These 
data suggest that AMPK is most likely has multiple targets during oocyte maturation. 
According to our experimental data, AMPK affects SAC activity to promote anaphase 
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onset, and prevents MAPK dephosphorylation to maintain metaphase II arrest, although it 
is not clear how these interactions occur. It is safe to speculate that AMPK may induce 
GVB by promoting MPF activity; PB formation by regulating MRLC, which is required 
for cytokinesis. 
 
 
Figure 4. 1 The Role of AMPK in Mouse Oocyte Maturation 
Figure summarizing the involvement of AMPK during mouse oocyte maturation.  
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The localization pattern of active AMPK is consistent with many other kinases 
that have been proven to regulate meiotic spindle. Although the reason why active 
AMPK adopts this localization pattern throughout maturation still remains elusive. Our 
evidence suggests that its localization of active AMPK has functional significance.  
Firstly, the germinal vesicle localization of active AMPK seems to be good 
indication of oocytes stimulation and impending meiotic resumption. The likely impact of 
this accumulation would be increased phosphorylation of its nuclear substrates. The 
meiosis-inducing action of AMPK is dependent on the microtubule integrity. Perturbing 
microtubule dynamics using microtubule-targeted agents disrupts the normal nuclear 
localization of active AMPK, which is consistent with the inhibitory effects of 
microtubule perturbants on meiotic induction mediated by AMPK. In somatic cells or 
yeast, many conditions induce nuclear localization of AMPKα subunit, such as alkaline 
pH (Hong and Carlson, 2007), heat shock (Kodiha et al. 2007), and leptin stimulation 
(Suzuki et al., 2007).  Even complicating, the upstream kinase, LKB1, was also found to 
shuttle between cytoplasm and nucleus (McGee et al., 2003). Compound C blocked both 
nuclear localization of active AMPK and GVB, indicating that such localization is vital 
for the induction process. However, induction can occur in its absence, since treatment 
with palmitoyl carnitine that directly activating downstream fatty acid oxidation pathway 
could significantly restore the GVB in nocodazole treated oocytes, though it should be 
noted that the extent of GVB after palmitoyl carnitine treatment did not reached the 
control level. Thus, we could speculate that activating other targets within the nucleus 
may also be involved that is required for stimulating MPF. An inhibitor of nuclear 
transport would be a valuable tool in further determining this mechanism. 
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The function of the spindle microtubule is well studied for later oocyte maturation 
stages. In contrast, less is known about its requirement during meiotic induction. I 
demonstrated that microtubule integrity is important for FSH-and AICAR-induced 
maturation. Perturbing microtubules blocked meiotic induction but not spontaneous 
maturation of oocytes. It is plausible to expect that during GV stage, the microtubule 
network is mainly required for protein transport (see p65 for details). One possible 
explanation would be that meiotic induction and spontaneous maturation are two 
different physiological processes in such that extra microtubule modulator-sensitive 
component is required for meiotic induction. Another explanation is mainly contributed 
by the different GVB kinetics of meiotic induction and spontaneous maturation of the 
mouse oocytes. Once released from the follicles, most mouse oocytes undergo GVB 
within an hour as opposed to hours in meiotic induction, which may be too soon for 
microtubule modulators to exert an effect.   
Secondly, the correct spindle pole localization of active AMPK seems to be 
correlated with the oocyte’s potential of completing maturation. Most LT oocytes arrest 
at metaphase I and have a high incidence of abnormal active AMPK localization at the 
spindle poles. AICAR stimulated meiotic progression of LT oocytes past metaphase I and 
significantly restored the normal spindle pole localization of active AMPK. This spindle 
pole localization of active AMPK is clearly depending on spindle microtubule integrity. 
Although we did not observe a reverse regulation of spindle microtubule by AMPK like 
in somatic cells, it is still possible that a residual AMPK activity is present after 
compound C treatment, which is sufficient to exert its effects on spindle dynamics. 
Recently, it has been found that blocking polo-like kinase 1 activity abolished activation 
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of AMPK and the correct spindle apparatus localization. Polo-like kinase 1 is an 
important protein that regulates spindle assembly, centrosome maturation, chromosome 
congression, separation and cytokinesis(Vazquez-Martin et al., 2011). It is likely that 
AMPK is also one of its down stream effectors in the oocytes.  
Thirdly, active AMPK also concentrated in the kinetochore region at metaphase I 
in addition to the spindle poles, which may indicate its role as a chromosome passenger 
protein. Unfortunately, we were unable to perform colocalization staining with 
kinetochore because the CENP-A antibody we purchased did not stain. Regardless, this 
subcellular pattern is consistent with the data that AICAR accelerated MAD2 loss from 
the kinetochore. How this interaction occurs remains to be identified, but research has 
shown that AMPK phosphorylates microtubule associated proteins (MAPs) (Mihaylova 
and Shaw, 2011), which may relate to this. 
Lastly, the midbody localization of the active AMPK during anaphase coincides 
with the future cleavage furrow that recruits MRLC. Cytokinesis is a highly coordinated 
process that can be divided into multiple stages; specification of the cleavage plane, 
ingression of the furrow, formation of the midbody, and abscission. Any defect of the 
above processes will lead to cytokinesis failure. Cytokinesis is also dependent on the 
actin filaments located outside of the furrow (Normand and King, 2010).  Blocking 
AMPK with compound C inhibited meiotic progression past metaphase I, but did not 
suppress spindle migration and the excessive polymerization of the F actin filaments. 
Interestingly, polo-like kinase 1 that is involved in the later stage of cytokinesis also 
directs AMPK phosphorylation of MRLC (Vazquez-Martin et al., 2012).  We are not sure 
whether there is any crosstalk between polo-like kinase and LKB1 regulation of AMPK, 
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especially on establishing cell polarity.  Based on these observations, I propose that 
AMPK is more involved in the later stages of the cytokinesis, such as myosin recruitment 
and activation, which are crucial for ingression of the furrow.  
The translocation of AMPK throughout maturation suggests a dynamic process at 
work, which also coincides with its potential functions at different stages. The germinal 
vesicle localization of AMPK is most likely dependent on microtubule meditated nuclear 
import. The poleward tanslocation of active AMPK might be dependent on the minus-end 
directed motor protein, dynein, which has been shown to be critical for spindle pole 
localization of the proteins such as NuMA and Eg5 (Merdes et al., 2000; Uteng et al., 
2008). In contrast, kinesin family members may mediate the midbody translocation of 
active AMPK. For instance, citron kinase (CIK-K), a major component of the contractile 
ring, requires kinesin family member 14 (KIF-14) for proper localization to the cleavage 
site (Gruneberg et al., 2006). It is likely that active AMPK is transported from spindle 
poles to the cleavage furrow by plus-end directed kinesin. However, I could not rule out 
the possibility that more AMPK is activated and recruited during anaphase. A GFP-
tagged fusion protein would be useful to track the movement of active AMPK during 
maturation.  
AMPK restored the meiotic behavior of LT oocytes, which includes release of 
metaphase I arrest, suppression of spontaneous activation, and correction of normal 
spindle pole localization of the active AMPK. Early development of CSF activity is not 
associated with the meiotic defect of LT oocytes. According to these observations, there 
are two likely scenarios whereby AMPK may correct the meiotic defects of LT oocytes; 
one of these would be that activation of AMPK overrides high levels of CSF activity to 
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induce anaphase, yet leaving MAPK1/3 activity intact. The second scenario would be that 
activation of AMPK completely restores the normal CSF profile during meiosis in that 
premature development of CSF activity is prevented but later helps maintain normal 
levels of activity during metaphase II arrest.  
 Although Western blot analysis of AMPK activity and levels in CEOs were not 
different from the control F1 mouse CEOs (data not shown), the direct assaying of 
AMPK by western analysis of oocyte phospho-ACC level was hindered by the poor 
reproductive performance of LT mice (Westerns of DOs require many more oocytes than 
those of CEOs). Regardless, evidence collected so far indicates that the malfunctioning of 
AMPK may be an important contributing factor to the LT oocyte phenotypes.  
In fact, in addition to LKB1, calcium/camodulin-dependent protein kinase kinase 
β (CaMKKβ) is another upstream activator of AMPK. Evidence suggests that CaMKKβ 
particularly activates AMPK in neurons and T cells (Mihaylova and Shaw, 2011). 
Although there has been report on the involvement of CaMKK on pig oocyte maturation, 
they did not distinguish CaMKKα and CaMKKβ (Xu et al., 2009). Furthermore, we are 
able to stain oocytes for active LKB1 but not CaMKK (Downs unpublished data). Thus, I 
favor the hypothesis that LKB1 pathway is predominantly active in the mouse oocytes.  
To why there are opposite consequences for AMPK activation on G2/M transition 
between somatic cells and mouse oocytes, below are some possible explanations. 1). 
Differential response to energy substrates. High glucose level suppresses GVB (see p43 
for details). 2) The origin of the AMP. In oocytes, elevated AMP mostly comes from 
degradation of cAMP, while the source is mostly ATP breakdown in somatic cells in 
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response to low energy and stress conditions. It is possible that a difference in AMP/ATP 
ratios between two types of cells may lead to the differential downstream effects.  
It is important to note that our experiments are mainly based on the 
pharmacological manipulation of AMPK. An AMPK null mouse model is a valuable tool 
for testing the absolute requirement for AMPK in meiotic regulation; however, the 
double knockout of both catalytic alpha subunit is embryonic lethal.  Thus, we are trying 
an alternative route to generate double knockout mice by using the Cre-loxP system in an 
α2 mutant mouse background, which should lead to a specific α1 subunit deletion in the 
oocytes that are already mutated for α2 allele (Lewandoski et al., 1997).  Currently, we 
have produced the α1 oocyte-specific knockout animals, and the α1 mutant oocytes did 
not exhibit any meiotic defects, which maybe due to the functional redundancy of two 
catalytic alpha subunits. However, when the female mice carrying α1 single mutant 
oocytes were mated with males that carry two homozygous floxed alleles for α1, the 
isolated embryos showed a significantly reduced rate of 2-cell embryo and blastocyst 
formation. This is likely caused by the active Cre recombinase in the oocyte that is still 
able to excise the floxed α1 allele in the sperm, rendering some of the resulting embryos 
null for α1(De-Vries et al., 2000). This result is promising and suggests that α1 subunit is 
critical for the early embryonic development. The generation of double knockout mice is 
still in progress.   
In conclusion, my study has shown a multifunctional role of the energy sensor, 
AMPK, in mouse oocyte maturation.  It will be important to determine whether similar 
functions for AMPK exist in human oocytes.  
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